Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Previous issues

Page Path
HOME > BROWSE ARTICLES > Previous issues
18 Previous issues
Filter
Filter
Article type
Keywords
Authors
Volume 33(1); March 2018
Prev issue Next issue
Namgok Lecture 2017
Adrenal gland
Bone Health in Adrenal Disorders
Beom-Jun Kim, Seung Hun Lee, Jung-Min Koh
Endocrinol Metab. 2018;33(1):1-8.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.1
  • 4,971 View
  • 50 Download
  • 14 Web of Science
  • 12 Crossref
AbstractAbstract PDFPubReader   ePub   

Secondary osteoporosis resulting from specific clinical disorders may be potentially reversible, and thus continuous efforts to find and adequately treat the secondary causes of skeletal fragility are critical to ameliorate fracture risk and to avoid unnecessary treatment with anti-osteoporotic drugs. Among the hyperfunctional adrenal masses, Cushing's syndrome, pheochromocytoma, and primary aldosteronism are receiving particularly great attention due to their high morbidity and mortality mainly by increasing cardiovascular risk. Interestingly, there is accumulating experimental and clinical evidence that adrenal hormones may have direct detrimental effects on bone metabolism as well. Thus, the present review discusses the possibility of adrenal disorders, especially focusing on pheochromocytoma and primary aldosteronism, as secondary causes of osteoporosis.

Citations

Citations to this article as recorded by  
  • High Risk of Fractures Within 7 Years of Diagnosis in Asian Patients With Inflammatory Bowel Diseases
    Hyung Jin Ahn, Ye-Jee Kim, Ho-Su Lee, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Beom-Jun Kim, Sang Hyoung Park
    Clinical Gastroenterology and Hepatology.2022; 20(5): e1022.     CrossRef
  • Change of Computed Tomography-Based Body Composition after Adrenalectomy in Patients with Pheochromocytoma
    Yousun Ko, Heeryoel Jeong, Seungwoo Khang, Jeongjin Lee, Kyung Won Kim, Beom-Jun Kim
    Cancers.2022; 14(8): 1967.     CrossRef
  • Bone and mineral metabolism in patients with primary aldosteronism: A systematic review and meta-analysis
    Anning Wang, Yuhan Wang, Hongzhou Liu, Xiaodong Hu, Jiefei Li, Huaijin Xu, Zhimei Nie, Lingjing Zhang, Zhaohui Lyu
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • The Entity of Connshing Syndrome: Primary Aldosteronism with Autonomous Cortisol Secretion
    Mara Carsote
    Diagnostics.2022; 12(11): 2772.     CrossRef
  • Elemental profiling of adrenal adenomas in solid tissue and blood samples by ICP-MS and ICP-OES
    Jovana Jagodić, Branislav Rovčanin, Đurđa Krstić, Ivan Paunović, Vladan Živaljević, Dragan Manojlović, Aleksandar Stojsavljević
    Microchemical Journal.2021; 165: 106194.     CrossRef
  • Aldosterone Inhibits In Vitro Myogenesis by Increasing Intracellular Oxidative Stress via Mineralocorticoid Receptor
    Jin Young Lee, Da Ae Kim, Eunah Choi, Yun Sun Lee, So Jeong Park, Beom-Jun Kim
    Endocrinology and Metabolism.2021; 36(4): 865.     CrossRef
  • Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service
    Jung Hee Kim, Hyemi Moon, Junghyun Noh, Juneyoung Lee, Sin Gon Kim
    Endocrinology and Metabolism.2020; 35(1): 157.     CrossRef
  • Pheochromocytoma and paraganglioma: An emerging cause of secondary osteoporosis
    Maki Yokomoto-Umakoshi, Hironobu Umakoshi, Tazuru Fukumoto, Yayoi Matsuda, Hiromi Nagata, Masatoshi Ogata, Hisaya Kawate, Takashi Miyazawa, Ryuichi Sakamoto, Yoshihiro Ogawa
    Bone.2020; 133: 115221.     CrossRef
  • Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism
    Christian Adolf, Leah T. Braun, Carmina T. Fuss, Stefanie Hahner, Heike Künzel, Laura Handgriff, Lisa Sturm, Daniel A. Heinrich, Holger Schneider, Martin Bidlingmaier, Martin Reincke
    Endocrine.2020; 69(3): 625.     CrossRef
  • Primary Aldosteronism and Bone Metabolism: A Systematic Review and Meta-Analysis
    Shaomin Shi, Chunyan Lu, Haoming Tian, Yan Ren, Tao Chen
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • Understanding and managing secondary osteoporosis
    Luciano Colangelo, Federica Biamonte, Jessica Pepe, Cristiana Cipriani, Salvatore Minisola
    Expert Review of Endocrinology & Metabolism.2019; 14(2): 111.     CrossRef
  • Evaluation of bone health in patients with adrenal tumors
    Shobana Athimulam, Irina Bancos
    Current Opinion in Endocrinology, Diabetes & Obesity.2019; 26(3): 125.     CrossRef
Close layer
Review Articles
Diabetes
Pathophysiology of Type 2 Diabetes in Koreans
Soo Heon Kwak, Kyong Soo Park
Endocrinol Metab. 2018;33(1):9-16.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.9
  • 5,352 View
  • 110 Download
  • 12 Web of Science
  • 10 Crossref
AbstractAbstract PDFPubReader   ePub   

The pathophysiology of type 2 diabetes is characterized by variable degrees of insulin resistance and impaired insulin secretion. Both genetic and environmental factors serve as etiologic factors. Recent genetic studies have identified at least 83 variants associated with diabetes. A significant number of these loci are thought to be involved in insulin secretion, either through β-cell development or β-cell dysfunction. Environmental factors have changed rapidly during the past half century, and the increased prevalence of obesity and diabetes can be attributed to these changes. Environmental factors may affect epigenetic changes and alter susceptibility to diabetes. A recent epidemiologic study revealed that Korean patients with type 2 diabetes already had impaired insulin secretion and insulin resistance 10 years before the onset of diabetes. Those who developed diabetes showed impaired β-cell compensation with an abrupt decrease in insulin secretion during the last 2 years before diabetes developed. The retrograde trajectory of the disposition index differed according to the baseline subgroups of insulin secretion and insulin sensitivity. We hope that obtaining a more detailed understanding of the perturbations in the major pathophysiologic process of diabetes on the individual level will eventually lead to the implementation of precision medicine and improved patient outcomes.

Citations

Citations to this article as recorded by  
  • Stress-Reducing Psychological Interventions as Adjuvant Therapies for Diabetic Chronic Wounds
    Isadora Pombeiro, João Moura, M. Graça Pereira, Eugénia Carvalho
    Current Diabetes Reviews.2022;[Epub]     CrossRef
  • Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell
    Kyung-Soo Kim, Yeon Kyung Choi, Mi Jin Kim, Jung Wook Hwang, Kyunghoon Min, Sang Youn Jung, Soo-Kyung Kim, Yong-Soo Choi, Yong-Wook Cho
    Diabetes & Metabolism Journal.2021; 45(2): 260.     CrossRef
  • Dose-Dependent Effect of Smoking on Risk of Diabetes Remains after Smoking Cessation: A Nationwide Population-Based Cohort Study in Korea
    Se Eun Park, Mi Hae Seo, Jung-Hwan Cho, Hyemi Kwon, Yang-Hyun Kim, Kyung-Do Han, Jin-Hyung Jung, Yong-Gyu Park, Eun-Jung Rhee, Won-Young Lee
    Diabetes & Metabolism Journal.2021; 45(4): 539.     CrossRef
  • DNA Methylation Changes Associated With Type 2 Diabetes and Diabetic Kidney Disease in an East Asian Population
    Hakyung Kim, Jae Hyun Bae, Kyong Soo Park, Joohon Sung, Soo Heon Kwak
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(10): e3837.     CrossRef
  • Associations among Obesity Degree, Glycemic Status, and Risk of Heart Failure in 9,720,220 Korean Adults
    Eun-Jung Rhee, Hyemi Kwon, Se Eun Park, Kyung-Do Han, Yong-Gyu Park, Yang-Hyun Kim, Won-Young Lee
    Diabetes & Metabolism Journal.2020; 44(4): 592.     CrossRef
  • Smoking as a Target for Prevention of Diabetes
    Ye Seul Yang, Tae Seo Sohn
    Diabetes & Metabolism Journal.2020; 44(3): 402.     CrossRef
  • Clinical characteristics of diabetic ketoacidosis in users and non-users of SGLT2 inhibitors
    J.Y. Jeon, S.-K. Kim, K.-S. Kim, S.O. Song, J.-S. Yun, B.-Y. Kim, C.-H. Kim, S.O. Park, S. Hong, D.H. Seo, J.A. Seo, J.H. Noh, D.J. Kim
    Diabetes & Metabolism.2019; 45(5): 453.     CrossRef
  • Identifying Pathogenic Variants of Monogenic Diabetes Using Targeted Panel Sequencing in an East Asian Population
    Seung Shin Park, Se Song Jang, Chang Ho Ahn, Jung Hee Kim, Hye Seung Jung, Young Min Cho, Young Ah Lee, Choong Ho Shin, Jong Hee Chae, Jae Hyun Kim, Sung Hee Choi, Hak C Jang, Jee Cheol Bae, Jong Cheol Won, Sung-Hoon Kim, Jong-Il Kim, Soo Heon Kwak, Kyong
    The Journal of Clinical Endocrinology & Metabolism.2019; 104(9): 4188.     CrossRef
  • Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease
    Daniela Stols-Gonçalves, Luca Schiliró Tristão, Peter Henneman, Max Nieuwdorp
    Current Diabetes Reports.2019;[Epub]     CrossRef
  • The cut-off values of surrogate measures for insulin resistance in the Korean population according to the Korean Genome and Epidemiology Study (KOGES)
    Bongyoung Kim, Hyun Young Choi, Wonhee Kim, Chiwon Ahn, Juncheol Lee, Jae Guk Kim, Jihoon Kim, Hyungoo Shin, Jae Myung Yu, Shinje Moon, Taulant Muka
    PLOS ONE.2018; 13(11): e0206994.     CrossRef
Close layer
Diabetes
Evolution of Diabetes Care in Hong Kong: From the Hong Kong Diabetes Register to JADE-PEARL Program to RAMP and PEP Program
Ivy H.Y. Ng, Kitty K.T. Cheung, Tiffany T.L. Yau, Elaine Chow, Risa Ozaki, Juliana C.N. Chan
Endocrinol Metab. 2018;33(1):17-32.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.17
  • 5,011 View
  • 67 Download
  • 15 Web of Science
  • 12 Crossref
AbstractAbstract PDFPubReader   ePub   

The rapid increase in diabetes prevalence globally has contributed to large increases in health care expenditure on diabetic complications, posing a major health burden to countries worldwide. Asians are commonly observed to have poorer β-cell function and greater insulin resistance compared to the Caucasian population, which is attributed by their lower lean body mass and central obesity. This “double phenotype” as well as the rising prevalence of young onset diabetes in Asia has placed Asians with diabetes at high risk of cardiovascular and renal complications, with cancer emerging as an important cause of morbidity and mortality. The experience from Hong Kong had demonstrated that a multifaceted approach, involving team-based integrated care, information technological advances, and patient empowerment programs were able to reduce the incidence of diabetic complications, hospitalizations, and mortality. System change and public policies to enhance implementation of such programs may provide solutions to combat the burgeoning health problem of diabetes at a societal level.

Citations

Citations to this article as recorded by  
  • Impact of Body Composition and Anemia on Accuracy of a Real-Time Continuous Glucose Monitor in Diabetes Patients on Continuous Ambulatory Peritoneal Dialysis
    James Ling, Jack K.C. Ng, Eric S.H. Lau, Andrea O.Y. Luk, Ronald C.W. Ma, Robert A. Vigersky, Philip K.T. Li, Juliana C.N. Chan, Cheuk Chun Szeto, Elaine Chow
    Diabetes Technology & Therapeutics.2024; 26(1): 70.     CrossRef
  • Levels and correlates of risk factor control in diabetes mellitus –ELSA-Brasil
    Bruna Cristine Chwal, Rodrigo Citton Padilha dos Reis, Maria Inês Schmidt, Bruce B. Duncan, Sandhi Maria Barreto, Rosane Harter Griep
    Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
  • Trends in risk factor control and treatment among patients with non‐alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory‐wide study
    Xinrong Zhang, Terry Cheuk‐Fung Yip, Yee‐Kit Tse, Vicki Wing‐Ki Hui, Guanlin Li, Huapeng Lin, Lilian Yan Liang, Jimmy Che‐To Lai, Mandy Sze‐Man Lai, Johnny T. K. Cheung, Henry Lik‐Yuen Chan, Stephen Lam Chan, Alice Pik‐Shan Kong, Grace Lai‐Hung Wong, Vinc
    Alimentary Pharmacology & Therapeutics.2023; 57(10): 1103.     CrossRef
  • Team-Based Diabetes Care in Ontario and Hong Kong: a Comparative Review
    Calvin Ke, Emaad Mohammad, Juliana C. N. Chan, Alice P. S. Kong, Fok-Han Leung, Baiju R. Shah, Douglas Lee, Andrea O. Luk, Ronald C. W. Ma, Elaine Chow, Xiaolin Wei
    Current Diabetes Reports.2023; 23(7): 135.     CrossRef
  • Team-Based Approach to Reduce Malignancies in People with Diabetes and Obesity
    Ziyue Zhu, Samuel Yeung Shan Wong, Joseph Jao Yiu Sung, Thomas Yuen Tung Lam
    Current Diabetes Reports.2023; 23(10): 253.     CrossRef
  • Professor Juliana Chung Ngor Chan: Tireless Trailblazer for Diabetes Research, Care, and Education in Asia
    Ronald C.W. Ma, Wing Yee So, Andrea O.Y. Luk
    Diabetes Care.2022; 45(10): 2207.     CrossRef
  • Predicting the Development of Myocardial Infarction in Middle-Aged Adults with Type 2 Diabetes: A Risk Model Generated from a Nationwide Population-Based Cohort Study in Korea
    Seung-Hwan Lee, Kyungdo Han, Hun-Sung Kim, Jae-Hyoung Cho, Kun-Ho Yoon, Mee Kyoung Kim
    Endocrinology and Metabolism.2020; 35(3): 636.     CrossRef
  • From Hong Kong Diabetes Register to JADE Program to RAMP-DM for Data-Driven Actions
    Juliana C.N. Chan, Lee-Ling Lim, Andrea O.Y. Luk, Risa Ozaki, Alice P.S. Kong, Ronald C.W. Ma, Wing-Yee So, Su-Vui Lo
    Diabetes Care.2019; 42(11): 2022.     CrossRef
  • Cholesterol levels and development of cardiovascular disease in Koreans with type 2 diabetes mellitus and without pre-existing cardiovascular disease
    Mee Kyoung Kim, Kyungdo Han, Han Na Joung, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon
    Cardiovascular Diabetology.2019;[Epub]     CrossRef
  • Effects of Variability in Blood Pressure, Glucose, and Cholesterol Concentrations, and Body Mass Index on End-Stage Renal Disease in the General Population of Korea
    Mee Kyoung Kim, Kyungdo Han, Hun-Sung Kim, Yong-Moon Park, Hyuk-Sang Kwon, Kun-Ho Yoon, Seung-Hwan Lee
    Journal of Clinical Medicine.2019; 8(5): 755.     CrossRef
  • Efficacy and safety of fixed‐dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double‐blind, controlled, phase 3 trial
    Ji Cheol Bae, Kyung Wan Min, Yong Hyun Kim, Kyoung‐Ah Kim, Eun‐Gyoung Hong, Cheol‐Young Park, Song Han, Bong‐Soo Cha
    Diabetes, Obesity and Metabolism.2019; 21(1): 103.     CrossRef
  • Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
    Yongin Cho, Myoung Soo Kim, Chung Mo Nam, Eun Seok Kang
    Scientific Reports.2019;[Epub]     CrossRef
Close layer
Obesity and Metabolism
Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease
Chrysoula Boutari, Nikolaos Perakakis, Christos Socrates Mantzoros
Endocrinol Metab. 2018;33(1):33-43.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.33
  • 8,611 View
  • 141 Download
  • 111 Web of Science
  • 106 Crossref
AbstractAbstract PDFPubReader   ePub   

Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease affecting 30% of the general population and 40% to 70% of obese individuals. Adipose tissue plays a crucial role in its pathogenesis, as it produces and secretes pro- and anti-inflammatory cytokines called adipokines. Adiponectin and leptin have well-determined actions in terms of NAFLD pathophysiology. Adiponectin deficiency is associated with a pro-inflammatory condition, as it is observed in obesity and other metabolic disorders. On the other hand, increased leptin levels, above the normal levels, act as a pro-inflammatory stimulus. Regarding other adipokines (resistin, visfatin, chemerin, retinol-binding protein 4, irisin), data about their contribution to NAFLD pathogenesis and progression are inconclusive. In addition, pharmacological agents like thiazolidinediones (pioglitazone and rosiglitazone), that are used in the management of NAFLD exert favourable effects on adipokine levels, which in turn may contribute to the improvement of liver function. This review summarizes the current knowledge and developments in the association between adipokines and NAFLD and discusses possible therapeutic implications targeting the modulation of adipokine levels as a potential tool for the treatment of NAFLD.

Citations

Citations to this article as recorded by  
  • Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
    Wasitha P. D. W. Thilakarathna, H. P. Vasantha Rupasinghe
    Molecules.2024; 29(3): 709.     CrossRef
  • The role of novel adipokines and adipose-derived extracellular vesicles (ADEVs): Connections and interactions in liver diseases
    Lijun Xie, Huiying Wang, Jinying Hu, Zhuoying Liu, Fang Hu
    Biochemical Pharmacology.2024; 222: 116104.     CrossRef
  • Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases
    Nikolaos Perakakis, Hani Harb, Benjamin G Hale, Zsuzsanna Varga, Charlotte Steenblock, Waldemar Kanczkowski, Vasileia Ismini Alexaki, Barbara Ludwig, Peter Mirtschink, Michele Solimena, Nicole Toepfner, Sebastian Zeissig, Manuel Gado, Irene Alma Abela, Fe
    The Lancet Diabetes & Endocrinology.2023; 11(9): 675.     CrossRef
  • Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice
    Kyung Eun Kim, Jaewoong Lee, Hyun Joo Shin, Eun Ae Jeong, Hye Min Jang, Yu Jeong Ahn, Hyeong Seok An, Jong Youl Lee, Meong Cheol Shin, Soo Kyoung Kim, Won Gi Yoo, Won Ho Kim, Gu Seob Roh
    Hepatology.2023; 77(3): 888.     CrossRef
  • Effect of Dietary Intervention, with or without Cointerventions, on Inflammatory Markers in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
    Renate L. Hall, Elena S. George, Audrey C. Tierney, Anjana J. Reddy
    Advances in Nutrition.2023; 14(3): 475.     CrossRef
  • The Anti-Obesity and Anti-Steatotic Effects of Chrysin in a Rat Model of Obesity Mediated through Modulating the Hepatic AMPK/mTOR/lipogenesis Pathways
    Ghaleb Oriquat, Inas M. Masoud, Maher A. Kamel, Hebatallah Mohammed Aboudeya, Marwa B. Bakir, Sara A. Shaker
    Molecules.2023; 28(4): 1734.     CrossRef
  • Association between caffeine intake and liver biomarkers in non-alcoholic fatty liver disease
    Kübra UÇAR, Evrim KAHRAMANOĞLU, Zeynep GÖKTAŞ
    Cukurova Medical Journal.2023; 48(1): 177.     CrossRef
  • Changes in liver enzymes are associated with changes in insulin resistance, inflammatory biomarkers and leptin in prepubertal children with obesity
    Rosario Valle-Martos, Luis Jiménez-Reina, Ramón Cañete, Rosario Martos, Miguel Valle, María Dolores Cañete
    Italian Journal of Pediatrics.2023;[Epub]     CrossRef
  • The key role of inflammation in the pathogenesis and management of obesity and CVD
    Chrysoula Boutari, Michael A. Hill, Claudio Procaccini, Giuseppe Matarese, Christos S. Mantzoros
    Metabolism.2023; 145: 155627.     CrossRef
  • Obesity and diabetes
    Chrysoula Boutari, Antea DeMarsilis, Christos S. Mantzoros
    Diabetes Research and Clinical Practice.2023; 202: 110773.     CrossRef
  • Identifying a distinct fibrosis subset of NAFLD via molecular profiling and the involvement of profibrotic macrophages
    Weiwei He, Yinxiang Huang, Xiulin Shi, Qingxuan Wang, Menghua Wu, Han Li, Qiuhong Liu, Xiaofang Zhang, Caoxin Huang, Xuejun Li
    Journal of Translational Medicine.2023;[Epub]     CrossRef
  • The emerging significance of mitochondrial targeted strategies in NAFLD treatment
    Tao Zhang, Yingli Nie, Jiliang Wang
    Life Sciences.2023; 329: 121943.     CrossRef
  • Association between leptin and NAFLD: a two-sample Mendelian randomization study
    Ziwei Guo, Hongbo Du, Yi Guo, Qian Jin, Ruijia Liu, Zhangjun Yun, Jiaxin Zhang, Xiaoke Li, Yong’an Ye
    European Journal of Medical Research.2023;[Epub]     CrossRef
  • Liver fat as risk factor of hepatic and cardiometabolic diseases
    Münevver Demir, Stefan R. Bornstein, Christos S. Mantzoros, Nikolaos Perakakis
    Obesity Reviews.2023;[Epub]     CrossRef
  • Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational Study
    Laura Valenzuela-Vallejo, Pavlina Chrysafi, Matina Kouvari, Valentina Guatibonza-Garcia, Sophia C. Mylonakis, Angeliki Katsarou, Ornella Verrastro, Georgios Markakis, Mohammed Eslam, Georgios Papatheodoridis, Geltrude Mingrone, Jacob George, Christos S. M
    Metabolism.2023; 148: 155694.     CrossRef
  • Linalool attenuates lipid accumulation and oxidative stress in metabolic dysfunction-associated steatotic liver disease via Sirt1/Akt/PPRA-α/AMPK and Nrf-2/HO-1 signaling pathways
    P. Tamilmani, V. V. Sathibabu Uddandrao, P. Chandrasekaran, G. Saravanan, Parim Brahma Naidu, S. Sengottuvelu, S. Vadivukkarasi
    Clinics and Research in Hepatology and Gastroenterology.2023; 47(10): 102231.     CrossRef
  • Uncovering the Cardiovascular Threat: A Comprehensive Examination of Liver Fibrosis and Subclinical Atherosclerosis in Non-alcoholic Fatty Liver Disease
    Niketa Sharma, Swarupa Chakole, Bhushan Wandile
    Cureus.2023;[Epub]     CrossRef
  • Fetal programming by androgen excess impairs liver lipid content and PPARg expression in adult rats
    Aimé Florencia Silva, Giselle Adriana Abruzzese, María José Ferrer, María Florencia Heber, Silvana Rocío Ferreira, Gloria Edith Cerrone, Alicia Beatriz Motta
    Journal of Developmental Origins of Health and Disease.2022; 13(3): 300.     CrossRef
  • Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19
    Adryana Cordeiro, Amanda Ribamar, Andrea Ramalho
    Clinics and Research in Hepatology and Gastroenterology.2022; 46(3): 101807.     CrossRef
  • Comparison of bioelectrical impedance analysis, mass index, and waist circumference in assessing risk for non-alcoholic steatohepatitis
    Katherine J.P. Schwenger, Alexander Kiu, Maryam AlAli, Amnah Alhanaee, Sandra E. Fischer, Johane P. Allard
    Nutrition.2022; 93: 111491.     CrossRef
  • Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease
    Juan Moreno-Vedia, Josefa Girona, Daiana Ibarretxe, Lluís Masana, Ricardo Rodríguez-Calvo
    Biomedicines.2022; 10(1): 197.     CrossRef
  • Predictive and Diagnostic Value of Serum Adipokines in Pregnant Women with Intrahepatic Cholestasis
    Nazan Yurtcu, Canan Soyer Caliskan, Huri Guvey, Samettin Celik, Safak Hatirnaz, Andrea Tinelli
    International Journal of Environmental Research and Public Health.2022; 19(4): 2254.     CrossRef
  • Symposium review: Adipose tissue endocrinology in the periparturient period of dairy cows
    Susanne Häussler, Hassan Sadri, Morteza H. Ghaffari, Helga Sauerwein
    Journal of Dairy Science.2022; 105(4): 3648.     CrossRef
  • Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn?
    Maria Martin-Grau, Vannina G Marrachelli, Daniel Monleon
    World Journal of Hepatology.2022; 14(2): 304.     CrossRef
  • Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown
    Simona Alexandra Iacob, Diana Gabriela Iacob
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver Disease
    Baran Ghezelbash, Nader Shahrokhi, Mohammad Khaksari, Gholamreza Asadikaram, Maryam Shahrokhi, Sara Shirazpour
    Chinese Journal of Integrative Medicine.2022; 28(6): 531.     CrossRef
  • The pathophysiological mechanism between hypopituitarism and nonalcoholic fatty liver disease
    Xinhe Zhang, Haoyu Tian, Yiling Li
    iLIVER.2022; 1(1): 65.     CrossRef
  • Correlation of Adiponectin Gene Polymorphisms rs266729 and rs3774261 With Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
    Yong-Tian Zheng, Tian-Mei Xiao, Chan-Xian Wu, Jin-Yan Cheng, Le-Yu Li
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • An Overview of the TRP-Oxidative Stress Axis in Metabolic Syndrome: Insights for Novel Therapeutic Approaches
    Mizael C. Araújo, Suzany H. S. Soczek, Jaqueline P. Pontes, Leonardo A. C. Marques, Gabriela S. Santos, Gisele Simão, Laryssa R. Bueno, Daniele Maria-Ferreira, Marcelo N. Muscará, Elizabeth S. Fernandes
    Cells.2022; 11(8): 1292.     CrossRef
  • Skeletal muscle mass to visceral fat area ratio as a predictor of NAFLD in lean and overweight men and women with effect modification by sex
    Yoosun Cho, Yoosoo Chang, Seungho Ryu, Hyun‐Suk Jung, Chan‐won Kim, Hyungseok Oh, Mi Kyung Kim, Won Sohn, Hocheol Shin, Sarah H. Wild, Christopher D. Byrne
    Hepatology Communications.2022; 6(9): 2238.     CrossRef
  • The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
    Yuxian Yang, Shuting Li, Yuechao Xu, Jing Ke, Dong Zhao
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1505.     CrossRef
  • Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena
    Aamir Bashir, Ajay Duseja, Arka De, Manu Mehta, Pramil Tiwari
    Liver Research.2022; 6(2): 72.     CrossRef
  • Relationship between Liver Stiffness and Steatosis in Obesity Conditions: In Vivo and In Vitro Studies
    Francesca Baldini, Mohamad Khalil, Alice Bartolozzi, Massimo Vassalli, Agostino Di Ciaula, Piero Portincasa, Laura Vergani
    Biomolecules.2022; 12(5): 733.     CrossRef
  • Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs
    Eleftheria Galatou, Elena Mourelatou, Sophia Hatziantoniou, Ioannis S. Vizirianakis
    Antioxidants.2022; 11(6): 1060.     CrossRef
  • The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study
    Osama Hamid, Ahmed Eltelbany, Abdul Mohammed, Khaled Alsabbagh Alchirazi, Sushrut Trakroo, Imad Asaad
    Annals of Hepatology.2022; 27(5): 100727.     CrossRef
  • Helicobacter Pylori-Induced Gastric Infections: From Pathogenesis to Novel Therapeutic Approaches Using Silver Nanoparticles
    Romelia Pop, Alexandru-Flaviu Tăbăran, Andrei Paul Ungur, Andrada Negoescu, Cornel Cătoi
    Pharmaceutics.2022; 14(7): 1463.     CrossRef
  • Traumatic brain injury alters the gut-derived serotonergic system and associated peripheral organs
    Natosha M. Mercado, Guanglin Zhang, Zhe Ying, Fernando Gómez-Pinilla
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2022; 1868(11): 166491.     CrossRef
  • Detangling the interrelations between MAFLD, insulin resistance, and key hormones
    Shreya C. Pal, Mohammed Eslam, Nahum Mendez-Sanchez
    Hormones.2022; 21(4): 573.     CrossRef
  • Historical Changes in Weight Classes and the Influence of NAFLD Prevalence: A Population Analysis of 34,486 Individuals
    Benjamin Kai Yi Nah, Cheng Han Ng, Kai En Chan, Caitlyn Tan, Manik Aggarwal, Rebecca Wenling Zeng, Jieling Xiao, Yip Han Chin, Eunice X. X. Tan, Yi Ping Ren, Douglas Chee, Jonathan Neo, Nicholas W. S. Chew, Michael Tseng, Mohammad Shadab Siddiqui, Arun J.
    International Journal of Environmental Research and Public Health.2022; 19(16): 9935.     CrossRef
  • Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?
    Vera Francisco, Maria Jesus Sanz, José T. Real, Patrice Marques, Maurizio Capuozzo, Djedjiga Ait Eldjoudi, Oreste Gualillo
    Biology.2022; 11(8): 1237.     CrossRef
  • Fatty Liver/Adipose Tissue Dual‐Targeting Nanoparticles with Heme Oxygenase‐1 Inducer for Amelioration of Obesity, Obesity‐Induced Type 2 Diabetes, and Steatohepatitis
    Juhyeong Hong, Yong‐Hee Kim
    Advanced Science.2022;[Epub]     CrossRef
  • Genome-wide association and Mendelian randomization study of fibroblast growth factor 21 reveals causal associations with hyperlipidemia and possibly NASH
    Susanna C. Larsson, Karl Michaëlsson, Marina Mola-Caminal, Jonas Höijer, Christos S. Mantzoros
    Metabolism.2022; 137: 155329.     CrossRef
  • Gender differences in the ideal cutoffs of visceral fat area for predicting MAFLD in China
    Pingping Yu, Huachao Yang, Xiaoya Qi, Ruixue Bai, Shouqin Zhang, Jianping Gong, Ying Mei, Peng Hu
    Lipids in Health and Disease.2022;[Epub]     CrossRef
  • Apelin and chemerin receptors are G protein-coupled receptors involved in metabolic as well as reproductive functions: Potential therapeutic implications?
    Anthony Estienne, Alice Bongrani, Pascal Froment, Joëlle Dupont
    Current Opinion in Endocrine and Metabolic Research.2021; 16: 86.     CrossRef
  • Metformin dose increase versus added linagliptin in non‐alcoholic fatty liver disease and type 2 diabetes: An analysis of the J‐LINK study
    Yasuji Komorizono, Kaori Hosoyamada, Naoko Imamura, Shoko Kajiya, Yasuhiro Hashiguchi, Norio Ueyama, Hirohiko Shinmaki, Nobuyuki Koriyama, Masako Tsukasa, Tetsuro Kamada
    Diabetes, Obesity and Metabolism.2021; 23(3): 832.     CrossRef
  • Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population
    I-Ting Lin, Mei-Yueh Lee, Chih-Wen Wang, Da-Wei Wu, Szu-Chia Chen
    International Journal of Environmental Research and Public Health.2021; 18(3): 857.     CrossRef
  • Leptin in Leanness and Obesity
    Nikolaos Perakakis, Olivia M. Farr, Christos S. Mantzoros
    Journal of the American College of Cardiology.2021; 77(6): 745.     CrossRef
  • Severe insulin resistance syndromes
    Angeliki M. Angelidi, Andreas Filippaios, Christos S. Mantzoros
    Journal of Clinical Investigation.2021;[Epub]     CrossRef
  • Liver Enzymes Correlate With Metabolic Syndrome, Inflammation, and Endothelial Dysfunction in Prepubertal Children With Obesity
    Rosario Valle-Martos, Miguel Valle, Rosario Martos, Ramón Cañete, Luis Jiménez-Reina, María Dolores Cañete
    Frontiers in Pediatrics.2021;[Epub]     CrossRef
  • From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
    Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Natalia Wasilewska, Dariusz Marek Lebensztejn
    Journal of Clinical Medicine.2021; 10(5): 924.     CrossRef
  • Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives
    Christina-Maria Flessa, Ioannis Kyrou, Narjes Nasiri-Ansari, Gregory Kaltsas, Athanasios G. Papavassiliou, Eva Kassi, Harpal S. Randeva
    Current Obesity Reports.2021; 10(2): 134.     CrossRef
  • Role of Insulin Resistance in MAFLD
    Yoshitaka Sakurai, Naoto Kubota, Toshimasa Yamauchi, Takashi Kadowaki
    International Journal of Molecular Sciences.2021; 22(8): 4156.     CrossRef
  • Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non‐alcoholic steatohepatitis
    Nikolaos Perakakis, Konstantinos Stefanakis, Michael Feigh, Sanne S. Veidal, Christos S. Mantzoros
    Liver International.2021; 41(8): 1853.     CrossRef
  • Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
    Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh
    International Journal of Molecular Sciences.2021; 22(9): 4495.     CrossRef
  • Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
    Oriol Juanola, Sebastián Martínez-López, Rubén Francés, Isabel Gómez-Hurtado
    International Journal of Environmental Research and Public Health.2021; 18(10): 5227.     CrossRef
  • Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis
    Abdulrahman Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu
    Journal of Clinical Medicine.2021; 10(14): 3029.     CrossRef
  • Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents
    Farah D.R. Al-Baiaty, Aziana Ismail, Zarina Abdul Latiff, Khairul Najmi Muhammad Nawawi, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar
    Frontiers in Pediatrics.2021;[Epub]     CrossRef
  • Adipokines in Insulin Resistance: Current Updates
    Utpal Jagdish Dongre
    Biosciences Biotechnology Research Asia.2021; 18(2): 357.     CrossRef
  • Metabolic Effects of Gastrectomy and Duodenal Bypass in Early Gastric Cancer Patients with T2DM: A Prospective Single-Center Cohort Study
    Young Ki Lee, Eun Kyung Lee, You Jin Lee, Bang Wool Eom, Hong Man Yoon, Young-Il Kim, Soo Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Sun-Young Kong, Min Kyong Yoo, Yul Hwangbo, Young-Woo Kim, Il Ju Choi, Hak Jin Kim, Mi Hyang Kwak, Keun Won Ryu
    Journal of Clinical Medicine.2021; 10(17): 4008.     CrossRef
  • Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial
    Fateme Kooshki, Fardin Moradi, Arash Karimi, Hamid Reza Niazkar, Manouchehr Khoshbaten, Vahid Maleki, Bahram Pourghassem Gargari
    European Journal of Gastroenterology & Hepatology.2021; 33(10): 1298.     CrossRef
  • Specificities of lipotoxicity of free fatty acids and cytokine profile in patients with chronic diffuse liver diseases
    V. I. Didenko, I. A. Klenina, О. M. Tatarchuk, O. I. Hrabovska, O. P. Petishko
    Regulatory Mechanisms in Biosystems.2021; 13(1): 3.     CrossRef
  • Markers of progression of liver fibrotic changes in patients with chronic toxic drug-induced hepatitis
    V.I. Didenko, O.M. Tatarchuk, O.P. Petishko, I.S. Konenko, S.L. Melanich
    GASTROENTEROLOGY.2021; 55(2): 91.     CrossRef
  • Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD/NASH
    Simona Pompili, Antonella Vetuschi, Eugenio Gaudio, Alessandra Tessitore, Roberta Capelli, Edoardo Alesse, Giovanni Latella, Roberta Sferra, Paolo Onori
    Nutrition.2020; 75-76: 110782.     CrossRef
  • Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD
    Stergios A Polyzos, Nikolaos Perakakis, Chrysoula Boutari, Jannis Kountouras, Wael Ghaly, Athanasios D Anastasilakis, Asterios Karagiannis, Christos S Mantzoros
    The Journal of Clinical Endocrinology & Metabolism.2020; 105(3): e390.     CrossRef
  • Inflammatory Mechanisms of HCC Development
    Maria Grazia Refolo, Caterina Messa, Vito Guerra, Brian Irving Carr, Rosalba D’Alessandro
    Cancers.2020; 12(3): 641.     CrossRef
  • Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
    Robert F. Schwabe, Ira Tabas, Utpal B. Pajvani
    Gastroenterology.2020; 158(7): 1913.     CrossRef
  • Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
    Chan-Hee Jung, Eun-Jung Rhee, Hyemi Kwon, Yoosoo Chang, Seungho Ryu, Won-Young Lee
    Endocrinology and Metabolism.2020; 35(1): 165.     CrossRef
  • Alpha-syntrophin deficiency protects against non-alcoholic steatohepatitis associated increase of macrophages, CD8+ T-cells and galectin-3 in the liver
    Lisa Rein-Fischboeck, Elisabeth M. Haberl, Ganimete Bajraktari, Susanne Feder, Rebekka Pohl, Elke Eggenhofer, Christa Buechler
    Experimental and Molecular Pathology.2020; 113: 104363.     CrossRef
  • Targeting of Secretory Proteins as a Therapeutic Strategy for Treatment of Nonalcoholic Steatohepatitis (NASH)
    Kyeongjin Kim, Kook Hwan Kim
    International Journal of Molecular Sciences.2020; 21(7): 2296.     CrossRef
  • Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block
    Vasilios G. Athyros, Stergios A. Polyzos, Jiannis Kountouras, Niki Katsiki, Panagiotis Anagnostis, Michael Doumas, Christos S. Mantzoros
    Current Vascular Pharmacology.2020; 18(2): 172.     CrossRef
  • High body mass index hinders fibrosis improvement in patients receiving long‐term tenofovir therapy in hepatitis B virus‐related cirrhosis
    Young Eun Chon, Kyu Sik Jung, Yeonjung Ha, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang, Sang Hoon Ahn, Do Young Kim, Kwang‐Hyub Han, Jun Yong Park
    Journal of Viral Hepatitis.2020; 27(11): 1119.     CrossRef
  • The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
    Nikolaos Perakakis, Konstantinos Stefanakis, Christos S. Mantzoros
    Metabolism.2020; 111: 154320.     CrossRef
  • The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis
    Nikolaos Perakakis, Aditya Joshi, Natia Peradze, Konstantinos Stefanakis, Georgia Li, Michael Feigh, Sanne Skovgard Veidal, Glenn Rosen, Michael Fleming, Christos S. Mantzoros
    Hepatology Communications.2020; 4(9): 1302.     CrossRef
  • Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease
    Doaa El Amrousy, Dalia El-Afify
    Cytokine.2020; 135: 155215.     CrossRef
  • The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: A double‐blind randomized clinical trial
    Farnaz Kavianipour, Naheed Aryaeian, Marjan Mokhtare, Reyhanesadat Mirnasrollahiparsa, Leila Jannani, Shahram Agah, Sodabeh Fallah, Nariman Moradi
    Phytotherapy Research.2020; 34(12): 3367.     CrossRef
  • Hepatic Lipidomics and Molecular Imaging in a Murine Non-Alcoholic Fatty Liver Disease Model: Insights into Molecular Mechanisms
    Ricardo Rodríguez-Calvo, Sara Samino, Josefa Girona, Neus Martínez-Micaelo, Pere Ràfols, María García-Altares, Sandra Guaita-Esteruelas, Alexandra Junza, Mercedes Heras, Oscar Yanes, Xavier Correig, Lluis Masana
    Biomolecules.2020; 10(9): 1275.     CrossRef
  • The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling
    Samukelisiwe C. Shabalala, Phiwayinkosi V. Dludla, Lawrence Mabasa, Abidemi P. Kappo, Albertus K. Basson, Carmen Pheiffer, Rabia Johnson
    Biomedicine & Pharmacotherapy.2020; 131: 110785.     CrossRef
  • NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
    Na Xie, Lu Zhang, Wei Gao, Canhua Huang, Peter Ernst Huber, Xiaobo Zhou, Changlong Li, Guobo Shen, Bingwen Zou
    Signal Transduction and Targeted Therapy.2020;[Epub]     CrossRef
  • Neurochemical regulators of food behavior for pharmacological treatment of obesity: current status and future prospects
    Gayane Sargis Vardanyan, Hasmik Samvel Harutyunyan, Michail Iosif Aghajanov, Ruben Sargis Vardanyan
    Future Medicinal Chemistry.2020; 12(20): 1865.     CrossRef
  • Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases
    Maite Martínez-Uña, Yaiza López-Mancheño, Carlos Diéguez, Manuel A. Fernández-Rojo, Marta G. Novelle
    International Journal of Molecular Sciences.2020; 21(24): 9368.     CrossRef
  • Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression
    Ming-Ling Chang, Zinger Yang, Sien-Sing Yang
    International Journal of Molecular Sciences.2020; 21(21): 8308.     CrossRef
  • CHANGES IN CARBOHYDRATE METABOLISM AND ADIPOCYTOKINES UNDER THE INFLUENCE OF TREATMENT OF PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER IN COMBINATION WITH OBESITY USING ADAMETHIONINUM AND ARGININE GLUTAMATE
    N. R. Matkovska
    Medical and Clinical Chemistry.2020; (3): 17.     CrossRef
  • Effects of sodium-glucose co-transporter-2 (SGLT2) inhibitors on non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Ex quo et quo vadimus?
    Niki Katsiki, Nikolaos Perakakis, Christos Mantzoros
    Metabolism.2019; 98: iii.     CrossRef
  • Role of Soluble Adiponectin Receptor 2 in Non-Alcoholic Fatty Liver Disease in Children
    Gulsah Kaya Aksoy, Reha Artan, Cihat Aksoy, Sebahat Özdem, Atike Atalay, Aygen Yılmaz
    Pediatric Gastroenterology, Hepatology & Nutrition.2019; 22(5): 470.     CrossRef
  • Determinants of ectopic liver fat in metabolic disease
    Anja Bosy-Westphal, Wiebke Braun, Viktoria Albrecht, Manfred J. Müller
    European Journal of Clinical Nutrition.2019; 73(2): 209.     CrossRef
  • Involvement of the hepatic branch of the vagus nerve in the regulation of plasma adipokine levels in rats fed a high-fructose diet
    Naoto Hashimoto, Manabu Wakagi, Katsunari Ippoushi, Yuko Takano-Ishikawa
    The Journal of Nutritional Biochemistry.2019; 71: 90.     CrossRef
  • Fat and Sugar—A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease
    Ines C.M. Simoes, Justyna Janikiewicz, Judith Bauer, Agnieszka Karkucinska-Wieckowska, Piotr Kalinowski, Agnieszka Dobrzyń, Andrzej Wolski, Maciej Pronicki, Krzysztof Zieniewicz, Paweł Dobrzyń, Marcin Krawczyk, Hans Zischka, Mariusz R. Wieckowski, Yaiza P
    Nutrients.2019; 11(12): 2871.     CrossRef
  • Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood
    Susann Weihrauch-Blüher, Peter Schwarz, Jan-Henning Klusmann
    Metabolism.2019; 92: 147.     CrossRef
  • Effects of moderate-intensity continuous training and high-intensity interval training on serum levels of Resistin, Chemerin and liver enzymes in Streptozotocin-Nicotinamide induced Type-2 diabetic rats
    Parastesh Mohammad, Khosravi Zadeh Esfandiar, Saremi Abbas, Rekabtalae Ahoora
    Journal of Diabetes & Metabolic Disorders.2019; 18(2): 379.     CrossRef
  • Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
    Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros
    Metabolism.2019; 92: 82.     CrossRef
  • The Latest Insights into Adipokines in Diabetes
    Won Kon Kim, Kwang-Hee Bae, Sang Chul Lee, Kyoung-Jin Oh
    Journal of Clinical Medicine.2019; 8(11): 1874.     CrossRef
  • Postprandial leptin and adiponectin in response to sugar and fat in obese and normal weight individuals
    M. A. Larsen, V. T. Isaksen, E. J. Paulssen, R. Goll, J. R. Florholmen
    Endocrine.2019; 66(3): 517.     CrossRef
  • First demonstration of protective effects of purified mushroom polysaccharide-peptides against fatty liver injury and the mechanisms involved
    Shuang Zhao, Shuman Zhang, Weiwei Zhang, Yi Gao, Chengbo Rong, Hexiang Wang, Yu Liu, Jack Ho Wong, Tzibun Ng
    Scientific Reports.2019;[Epub]     CrossRef
  • Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date
    Somaya Albhaisi, Arun J. Sanyal
    Pharmaceutical Medicine.2019; 33(6): 451.     CrossRef
  • Adiponectin rs2241766 and rs266729 gene polymorphisms in non-alcoholic fatty liver disease
    Aida A. Mahmoud, Hoda M. Moghazy, Laila M. Yousef, Asmaa N. Mohammad
    Gene Reports.2019; 15: 100381.     CrossRef
  • Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study
    Nikolaos Perakakis, Stergios A. Polyzos, Alireza Yazdani, Aleix Sala-Vila, Jannis Kountouras, Athanasios D. Anastasilakis, Christos S. Mantzoros
    Metabolism.2019; 101: 154005.     CrossRef
  • Association between Helicobacter pylori infection and nonalcoholic fatty liver
    Rongqiang Liu, Qiuli Liu, Ying He, Wenqing Shi, Qianhui Xu, Qing Yuan, Qi Lin, Biao Li, Lei Ye, Youlan Min, Peiwen Zhu, Yi Shao
    Medicine.2019; 98(44): e17781.     CrossRef
  • CHANGES IN CARBOHYDRATE METABOLISM IN PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE DEPENDING ON THE STAGE OF DECOMPENSATION
    Nataliia Matkovska, Nataliia Virstiuk, Uliana Balan
    International Academy Journal Web of Scholar.2019; (6(36)): 17.     CrossRef
  • Non-alcoholic fatty liver disease and colorectal cancer: A marker of risk or common causation?
    Niki Katsiki, Dimitri P. Mikhailidis, Christos Mantzoros
    Metabolism.2018; 87: A10.     CrossRef
  • Critical Roles of microRNAs in the Pathogenesis of Fatty Liver: New Advances, Challenges, and Potential Directions
    Chenggui Miao, Zhongwen Xie, Jun Chang
    Biochemical Genetics.2018; 56(5): 423.     CrossRef
  • Alpha-syntrophin dependent expression of tubulin alpha 8 protein in hepatocytes
    Lisa Rein-Fischboeck, Ganimete Bajraktari, Rebekka Pohl, Susanne Feder, Kristina Eisinger, Wolfgang Mages, Elisabeth M. Haberl, Christa Buechler
    Journal of Physiology and Biochemistry.2018; 74(4): 511.     CrossRef
  • Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches
    Kook Hwan Kim, Myung-Shik Lee
    Frontiers in Endocrinology.2018;[Epub]     CrossRef
  • Helicobacter pyloriand extragastric diseases: A review
    Antonietta Gerarda Gravina, Rocco Maurizio Zagari, Cristiana De Musis, Lorenzo Romano, Carmelina Loguercio, Marco Romano
    World Journal of Gastroenterology.2018; 24(29): 3204.     CrossRef
  • Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl‑CoA desaturase‑1, lipase activity, leptin and resistin
    Hessah Al‑Muzafar, Kamal Amin
    Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
  • Impact of weight cycling on CTRP3 expression, adipose tissue inflammation and insulin sensitivity in C57BL/6J mice
    Xin Li, Li Jiang, Miao Yang, Yu‑Wen Wu, Jia‑Zhong Sun
    Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
  • Analysis of non‑alcoholic fatty liver disease microRNA expression spectra in rat liver tissues
    Jiao Nie, Chang‑Ping Li, Jue‑Hong Li, Xia Chen, Xiaoling Zhong
    Molecular Medicine Reports.2018;[Epub]     CrossRef
Close layer
Miscellaneous
Evidence of the Possible Harm of Endocrine-Disrupting Chemicals in Humans: Ongoing Debates and Key Issues
Duk-Hee Lee
Endocrinol Metab. 2018;33(1):44-52.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.44
  • 10,037 View
  • 134 Download
  • 43 Web of Science
  • 44 Crossref
AbstractAbstract PDFPubReader   ePub   

Evidence has emerged that endocrine-disrupting chemicals (EDCs) can produce adverse effects, even at low doses that are assumed safe. However, systemic reviews and meta-analyses focusing on human studies, especially of EDCs with short half-lives, have demonstrated inconsistent results. Epidemiological studies have insuperable methodological limitations, including the unpredictable net effects of mixtures, non-monotonic dose-response relationships, the non-existence of unexposed groups, and the low reliability of exposure assessment. Thus, despite increases in EDC-linked diseases, traditional epidemiological studies based on individual measurements of EDCs in bio-specimens may fail to provide consistent results. The exposome has been suggested as a promising approach to address the uncertainties surrounding human studies, but it is never free from these methodological issues. Although exposure to EDCs during critical developmental periods is a major concern, continuous exposure to EDCs during non-critical periods is also harmful. Indeed, the evolutionary aspects of epigenetic programming triggered by EDCs during development should be considered because it is a key mechanism for developmental plasticity. Presently, living without EDCs is impossible due to their omnipresence. Importantly, there are lifestyles which can increase the excretion of EDCs or mitigate their harmful effects through the activation of mitohormesis or xenohormesis. Effectiveness of lifestyle interventions should be evaluated as practical ways against EDCs in the real world.

Citations

Citations to this article as recorded by  
  • Joint and interactive effects of metal mixtures on liver damage: Epidemiological evidence from repeated-measures study
    Guohuan Yin, Shuanzheng Zhao, Meiduo Zhao, Jing Xu, Xiaoyu Ge, Jingtao Wu, Yifan Zhou, Xiaolin Liu, Lanping Wei, Qun Xu
    Ecotoxicology and Environmental Safety.2024; 274: 116178.     CrossRef
  • Reconsidering “low‐dose”—Impacts of oral estrogen exposure during preimplantation embryo development
    Meret Schmidhauser, Anna‐Katharina Hankele, Susanne E. Ulbrich
    Molecular Reproduction and Development.2023; 90(7): 445.     CrossRef
  • Simultaneous estimation of methyl paraben, propyl paraben, and Bisphenol A in the plasma of Indian pregnant women using liquid chromatography–tandem mass spectrometry
    Rajesh Pradhan, Diksha Mishra, Sunil Kumar Dubey, Rajesh Khadgawat, Garima Kachhawa, Tarang Gupta, Rajeev Taliyan
    SEPARATION SCIENCE PLUS.2023;[Epub]     CrossRef
  • Influences of key factors on river water quality in urban and rural areas: A review
    Nguyen Tuan Anh, Le Duy Can, Nguyen Thi Nhan, Britta Schmalz, Tran Le Luu
    Case Studies in Chemical and Environmental Engineering.2023; 8: 100424.     CrossRef
  • Human health risk assessment for consumption of microplastics and plasticizing substances through marine species
    Virginia Montero, Yarenis Chinchilla, Luis Gómez, Adrián Flores, Alejandro Medaglia, Rossy Guillén, Ernesto Montero
    Environmental Research.2023; 237: 116843.     CrossRef
  • Effects of postnatal exposure to phthalate, bisphenol a, triclosan, parabens, and per- and poly-fluoroalkyl substances on maternal postpartum depression and infant neurodevelopment: a korean mother-infant pair cohort study
    Ju Hee Kim, Nalae Moon, Eunsun Ji, Hyo-Bang Moon
    Environmental Science and Pollution Research.2023; 30(42): 96384.     CrossRef
  • Cadmium exposure and thyroid hormone disruption: a systematic review and meta-analysis
    Seung Min Chung, Min Cheol Chang
    Reviews on Environmental Health.2023;[Epub]     CrossRef
  • Systematic review of prenatal exposure to endocrine disrupting chemicals and autism spectrum disorder in offspring
    Salvador Marí-Bauset, Isabel Peraita-Costa, Carolina Donat-Vargas, Agustín Llopis-González, Amelia Marí-Sanchis, Juan Llopis-Morales, María Morales Suárez-Varela
    Autism.2022; 26(1): 6.     CrossRef
  • Elucidation of xenoestrogen metabolism by non-targeted, stable isotope-assisted mass spectrometry in breast cancer cells
    Mira Flasch, Christoph Bueschl, Giorgia Del Favero, Gerhard Adam, Rainer Schuhmacher, Doris Marko, Benedikt Warth
    Environment International.2022; 158: 106940.     CrossRef
  • Fetoplacental vasculature as a model to study human cardiovascular endocrine disruption
    Margarida Lorigo, Elisa Cairrao
    Molecular Aspects of Medicine.2022; 87: 101054.     CrossRef
  • UV-B Filter Octylmethoxycinnamate Is a Modulator of the Serotonin and Histamine Receptors in Human Umbilical Arteries
    Margarida Lorigo, Carla Quintaneiro, Luiza Breitenfeld, Elisa Cairrao
    Biomedicines.2022; 10(5): 1054.     CrossRef
  • Microbiota analysis for risk assessment: evaluation of hazardous dietary substances and its potential role on the gut microbiome variability and dysbiosis
    Klara Cerk, Margarita Aguilera‐Gómez
    EFSA Journal.2022;[Epub]     CrossRef
  • Human adrenocortical carcinoma cell line (NCI-H295R): An in vitro screening model for the assessment of endocrine disruptors’ actions on steroidogenesis with an emphasis on cell ultrastructural features
    Hana Duranova, Veronika Fialkova, Veronika Valkova, Jana Bilcikova, Lucia Olexikova, Norbert Lukac, Peter Massanyi, Zuzana Knazicka
    Acta Histochemica.2022; 124(5): 151912.     CrossRef
  • Endocrine Disrupting Compounds (Nonylphenol and Bisphenol A)–Sources, Harmfulness and Laccase-Assisted Degradation in the Aquatic Environment
    Agnieszka Gałązka, Urszula Jankiewicz
    Microorganisms.2022; 10(11): 2236.     CrossRef
  • Subacute exposure to lead promotes disruption in the thyroid gland function in male and female rats
    Niedson Correia de Lima Junior, Juliana Franco Camilo, Pâmella Rodrigues do Carmo, Marcelle Novaes de Andrade, Bernardo Ferreira Braz, Ricardo Erthal Santelli, Lycia de Brito Gitirana, Andrea Claudia Freitas Ferreira, Denise Pires de Carvalho, Leandro Mir
    Environmental Pollution.2021; 274: 115889.     CrossRef
  • Plasticenta: First evidence of microplastics in human placenta
    Antonio Ragusa, Alessandro Svelato, Criselda Santacroce, Piera Catalano, Valentina Notarstefano, Oliana Carnevali, Fabrizio Papa, Mauro Ciro Antonio Rongioletti, Federico Baiocco, Simonetta Draghi, Elisabetta D'Amore, Denise Rinaldo, Maria Matta, Elisabet
    Environment International.2021; 146: 106274.     CrossRef
  • Impact of endocrine-disrupting chemicals on steroidogenesis and consequences on testicular function
    Casandra Walker, Samuel Garza, Vassilios Papadopoulos, Martine Culty
    Molecular and Cellular Endocrinology.2021; 527: 111215.     CrossRef
  • Best Achievements in Translational and Basic Thyroidology in 2020
    Sun Wook Cho, Young Joo Park
    Endocrinology and Metabolism.2021; 36(1): 36.     CrossRef
  • Endocrine disrupting chemicals in the pathogenesis of hypospadias; developmental and toxicological perspectives
    Deidre M. Mattiske, Andrew J. Pask
    Current Research in Toxicology.2021; 2: 179.     CrossRef
  • Perfluoroalkyl Chemicals and Male Reproductive Health: Do PFOA and PFOS Increase Risk for Male Infertility?
    Pheruza Tarapore, Bin Ouyang
    International Journal of Environmental Research and Public Health.2021; 18(7): 3794.     CrossRef
  • Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
    Raquel Cano, José Pérez, Lissé Dávila, Ángel Ortega, Yosselin Gómez, Nereida Valero-Cedeño, Heliana Parra, Alexander Manzano, Teresa Véliz Castro, María Albornoz, Gabriel Cano, Joselyn Rojas-Quintero, Maricarmen Chacín, Valmore Bermúdez
    International Journal of Molecular Sciences.2021; 22(9): 4807.     CrossRef
  • Microplastics in aquatic environment: Challenges and perspectives
    Aashlesha Chekkala Vivekanand, Sanjeeb Mohapatra, Vinay Kumar Tyagi
    Chemosphere.2021; 282: 131151.     CrossRef
  • A Review on Emerging Pollutants in the Water Environment: Existences, Health Effects and Treatment Processes
    Nor Zaiha Arman, Salmiati Salmiati, Azmi Aris, Mohd Razman Salim, Tasnia Hassan Nazifa, Mimi Suliza Muhamad, Marpongahtun Marpongahtun
    Water.2021; 13(22): 3258.     CrossRef
  • Urban-level environmental factors related to pediatric asthma
    Inês Paciência, João Cavaleiro Rufo
    Porto Biomedical Journal.2020; 5(1): e57.     CrossRef
  • Mechanisms of Testicular Disruption from Exposure to Bisphenol A and Phtalates
    Francesco Pallotti, Marianna Pelloni, Daniele Gianfrilli, Andrea Lenzi, Francesco Lombardo, Donatella Paoli
    Journal of Clinical Medicine.2020; 9(2): 471.     CrossRef
  • Developmental instability is associated with estrogenic endocrine disruption in the Chilean native fish species, Trichomycterus areolatus
    Angéline Bertin, Gautier Damiens, Daniela Castillo, Ricardo Figueroa, Christophe Minier, Nicolas Gouin
    Science of The Total Environment.2020; 714: 136638.     CrossRef
  • Tyrosinase nanocapsule based nano-biosensor for ultrasensitive and rapid detection of bisphenol A with excellent stability in different application scenarios
    Lingxia Wu, Xianbo Lu, Kai Niu, Dhanjai, Jiping Chen
    Biosensors and Bioelectronics.2020; 165: 112407.     CrossRef
  • The sex-specific effects of blood lead, mercury, and cadmium levels on hepatic steatosis and fibrosis: Korean nationwide cross-sectional study
    Seung Min Chung, Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
    Journal of Trace Elements in Medicine and Biology.2020; 62: 126601.     CrossRef
  • Diet: A Source of Endocrine Disruptors
    Hina Rashid, Saad S. Alqahtani, Saeed Alshahrani
    Endocrine, Metabolic & Immune Disorders - Drug Targets.2020; 20(5): 633.     CrossRef
  • Aryl-hydrocarbon receptor binding and the incidence of type 2 diabetes: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
    Bruce B. Duncan, Cristina D. Castilhos, Paula A. Bracco, Maria I. Schmidt, Sora Kang, Suyeol Im, Hong-Kyu Lee, Álvaro Vigo, Youngmi K. Pak
    Environmental Health.2020;[Epub]     CrossRef
  • Endocrinology and Metabolism Has Been Indexed in MEDLINE: A Major Achievement
    Won-Young Lee
    Endocrinology and Metabolism.2019; 34(2): 138.     CrossRef
  • Endocrine-disrupting chemicals: Effects on neuroendocrine systems and the neurobiology of social behavior
    Andrea C. Gore, Krittika Krishnan, Michael P. Reilly
    Hormones and Behavior.2019; 111: 7.     CrossRef
  • Removal of Pharmaceutical Contaminants in Wastewater Using Nanomaterials: A Comprehensive Review
    Anjali Chauhan, Devendra Sillu, Shekhar Agnihotri
    Current Drug Metabolism.2019; 20(6): 483.     CrossRef
  • Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease
    Olga Papalou, Eleni A. Kandaraki, George Papadakis, Evanthia Diamanti-Kandarakis
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Adverse Effect of Nonylphenol on the Reproductive System in F2 Male Mice : A Qualitative Change?
    Yong-Bin Kim, Yong-Pil Cheon, Donchan Choi, Sung-Ho Lee
    Development & Reproduction.2019; 23(3): 255.     CrossRef
  • Association of serum levels of p,p’- Dichlorodiphenyldichloroethylene (DDE) with type 2 diabetes in African American and Caucasian adult men from agricultural (Delta) and non-agricultural (non-Delta) regions of Mississippi
    Edward C. Meek, Dana Dale Jones, J. Allen Crow, Robert W. Wills, William H. Cooke, Janice E. Chambers
    Journal of Toxicology and Environmental Health, Part A.2019; 82(6): 387.     CrossRef
  • UV-B Filter Octylmethoxycinnamate Induces Vasorelaxation by Ca2+ Channel Inhibition and Guanylyl Cyclase Activation in Human Umbilical Arteries
    Margarida Lorigo, Carla Quintaneiro, Manuel Lemos, José Martinez-de-Oliveira, Luiza Breitenfeld, Elisa Cairrao
    International Journal of Molecular Sciences.2019; 20(6): 1376.     CrossRef
  • Transgenerational effects of BPA on female reproduction
    Stefania Santangeli, Claudia Consales, Francesca Pacchierotti, Hamid R. Habibi, Oliana Carnevali
    Science of The Total Environment.2019; 685: 1294.     CrossRef
  • Exposure to polybrominated biphenyl and stochastic epigenetic mutations: application of a novel epigenetic approach to environmental exposure in the Michigan polybrominated biphenyl registry
    Sarah W. Curtis, Dawayland O. Cobb, Varun Kilaru, Metrecia L. Terrell, M. Elizabeth Marder, Dana Boyd Barr, Carmen J. Marsit, Michele Marcus, Karen N. Conneely, Alicia K. Smith
    Epigenetics.2019; 14(10): 1003.     CrossRef
  • Determining the endocrine disruption potential of industrial chemicals using an integrative approach: Public databases, in vitro exposure, and modeling receptor interactions
    Olubusayo Alofe, Edwina Kisanga, Salmaan H. Inayat-Hussain, Masao Fukumura, Rolando Garcia-Milian, Lalith Perera, Vasilis Vasiliou, Shannon Whirledge
    Environment International.2019; 131: 104969.     CrossRef
  • 4-Nonylphenol-enhanced EZH2 and RNF2 expression, H3K27me3 and H2AK119ub1 marks resulting in silencing of p21CDKN1A in vitro
    Krishna Ghosh, Biji Chatterjee, Uma Maheswari, Mariyam Athifa, Santosh R Kanade
    Epigenomics.2019; 11(8): 899.     CrossRef
  • Sex-specific effects of blood cadmium on thyroid hormones and thyroid function status: Korean nationwide cross-sectional study
    Seung Min Chung, Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
    Journal of Trace Elements in Medicine and Biology.2019; 53: 55.     CrossRef
  • Assessment of the endocrine disrupting properties of Bisphenol AF according to the EU criteria and ECHA/EFSA guidance
    Laura Escrivá, Annika Hanberg, Johanna Zilliacus, Anna Beronius
    EFSA Journal.2019;[Epub]     CrossRef
  • Comparative assessment of endocrine disrupting compounds removal in heterotrophic and enriched nitrifying biomass
    Elissavet Kassotaki, Maite Pijuan, Ignasi Rodriguez-Roda, Gianluigi Buttiglieri
    Chemosphere.2019; 217: 659.     CrossRef
Close layer
Editorial
Thyroid
The Significance of Having an Excellent Patient's Comfort with Thyroid Core Needle Biopsy
Pierpaolo Trimboli, Luca Giovanella
Endocrinol Metab. 2018;33(1):53-54.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.53
  • 2,791 View
  • 40 Download
  • 2 Web of Science
  • 2 Crossref
PDFPubReader   ePub   

Citations

Citations to this article as recorded by  
  • A Matched-Pair Analysis of Nuclear Morphologic Features Between Core Needle Biopsy and Surgical Specimen in Thyroid Tumors Using a Deep Learning Model
    Faridul Haq, Andrey Bychkov, Chan Kwon Jung
    Endocrine Pathology.2022; 33(4): 472.     CrossRef
  • Does Radiofrequency Ablation Induce Neoplastic Changes in Benign Thyroid Nodules: A Preliminary Study
    Su Min Ha, Jun Young Shin, Jung Hwan Baek, Dong Eun Song, Sae Rom Chung, Young Jun Choi, Jeong Hyun Lee
    Endocrinology and Metabolism.2019; 34(2): 169.     CrossRef
Close layer
Original Articles
Diabetes
The Association between Persistent Hypertriglyceridemia and the Risk of Diabetes Development: The Kangbuk Samsung Health Study
Yu Hyun Kwon, Seul-Ki Kim, Jung Hwan Cho, Hyemi Kwon, Se Eun Park, Hyung-Geun Oh, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee
Endocrinol Metab. 2018;33(1):55-61.   Published online January 30, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.55
  • 4,133 View
  • 61 Download
  • 13 Web of Science
  • 14 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Hypertriglyceridemia is known to have an association with increased risks of insulin resistance and diabetes. The aim of this study was to investigate the risk of diabetes mellitus, according to changes in the concentrations of triglycerides, over time.

Methods

A total of 15,932 non-diabetic participants (mean age 43.2 years, 68% men) who attended five consecutive annual health check-ups at Kangbuk Samsung Hospital, between January 2010 and December 2014, were recruited. Participants were classified according to their triglyceride concentrations; normal (<150 mg/dL) and abnormal (≥150 mg/dL). According to the triglyceride levels in 2010 and 2012, subjects were divided into four groups: normal-normal, normal-abnormal, abnormal-normal, and abnormal-abnormal. The risk for incident diabetes was assessed in 2014.

Results

Among the total subjects, 67.5% belonged to the normal-normal group, 8.6% to the normal-abnormal group, 9.4% to the abnormal-normal group, and 14.5% to the abnormal-abnormal group. A total of 234 subjects (1.5%) were newly diagnosed with diabetes, between 2010 and 2014. Over 4 years, 1%, 1.5%, 2.1%, and 3.0% of the subjects developed diabetes in the normal-normal, normal-abnormal, abnormal-normal, and abnormal-abnormal groups, respectively. When the risk for incident diabetes was analyzed in the groups, after adjusting the confounding variables, a 1.58-fold increase in the risk of diabetes (95% confidence interval [CI], 1.10 to 2.26) was observed in the participants with persistent hypertriglyceridemia (abnormal-abnormal group). This was attenuated by further adjustments for body mass index (BMI) (hazard ratio, 1.25; 95% CI, 0.86 to 1.80).

Conclusion

In this large study population, persistent hypertriglyceridemia, over a period of 2 years, was significantly associated with the risk of incident diabetes, which was attenuated after adjustment for BMI.

Citations

Citations to this article as recorded by  
  • Cumulative exposure to hypertriglyceridemia and risk of type 2 diabetes in young adults
    Min-Kyung Lee, Kyungdo Han, Bongsung Kim, Jong-Dai Kim, Moon Jung Kim, Byungpyo Kim, Jung Heo, Jiyeon Ahn, Seo-Young Sohn, Jae-Hyuk Lee
    Diabetes Research and Clinical Practice.2024; 208: 111109.     CrossRef
  • Usefulness of SPISE Index for Screening and Detection of Early Stages of Insulin Resistance among Chilean Young Adults
    Isabel Pereyra González, Sandra Lopez-Arana
    Annals of Nutrition and Metabolism.2023; 79(4): 372.     CrossRef
  • Lipid variability in patients with diabetes mellitus
    Jeongmin Lee, Seung-Hwan Lee
    Cardiovascular Prevention and Pharmacotherapy.2023; 5(4): 126.     CrossRef
  • Sesamin: A Promising Therapeutic Agent for Ameliorating Symptoms of Diabetes
    Shu-Ming Huang, Cheng-Hung Chuang, Christine Joyce F. Rejano, Lemmuel L. Tayo, Cheng-Yang Hsieh, Steven Kuan-Hua Huang, Po-Wei Tsai
    Molecules.2023; 28(21): 7255.     CrossRef
  • Variability, Mean, and Baseline Values of Metabolic Parameters in Predicting Risk of Type 2 Diabetes
    Duong Duc Pham, Jaekyung Song, Yunwan Jeon, Ibrahimi Hajar, Chae Hun Leem
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(5): 1270.     CrossRef
  • Lipid Variability and Diabetes Mellitus
    Jeongmin Lee, Seung-Hwan Lee
    The Journal of Korean Diabetes.2022; 23(1): 28.     CrossRef
  • The Risk of Type 2 Diabetes Mellitus in a Russian Population Cohort According to Data from the HAPIEE Project
    Svetlana V. Mustafina, Oksana D. Rymar, Liliya V. Shcherbakova, Evgeniy G. Verevkin, Hynek Pikhart, Olga V. Sazonova, Yuliya I. Ragino, Galina I. Simonova, Martin Bobak, Sofia K. Malyutina, Mikhail I. Voevoda
    Journal of Personalized Medicine.2021; 11(2): 119.     CrossRef
  • The influence of VDR polymorphisms on the type 2 diabetes susceptibility in Chinese: an interaction with hypertriglyceridemia
    Dongdong Zhang, Cheng Cheng, Yan Wang, Yuan Xue, Yaping Liu, Yiming Liu, Mingming Feng, Ze Xu, Wenjie Li, Xing Li
    Molecular Genetics and Genomics.2021; 296(4): 837.     CrossRef
  • Development and validation of a new diabetes index for the risk classification of present and new-onset diabetes: multicohort study
    Shinje Moon, Ji-Yong Jang, Yumin Kim, Chang-Myung Oh
    Scientific Reports.2021;[Epub]     CrossRef
  • Hypertriglyceridemia as an Independent Predictor for Ten-Year Incidence of Diabetes in Thais
    Suranut Charoensri, Supatida Turnsaket, Chatlert Pongchaiyakul
    Vascular Health and Risk Management.2021; Volume 17: 519.     CrossRef
  • Prevalence and Current Management of Cardiovascular Risk Factors in Korean Adults Based on Fact Sheets
    Eun-Jung Rhee
    Endocrinology and Metabolism.2020; 35(1): 85.     CrossRef
  • HDL-Cholesterol, Its Variability, and the Risk of Diabetes: A Nationwide Population-Based Study
    Seung-Hwan Lee, Hun-Sung Kim, Yong-Moon Park, Hyuk-Sang Kwon, Kun-Ho Yoon, Kyungdo Han, Mee Kyoung Kim
    The Journal of Clinical Endocrinology & Metabolism.2019; 104(11): 5633.     CrossRef
  • Response: The Association between Persistent Hypertriglyceridemia and the Risk of Diabetes Development: The Kangbuk Samsung Health Study (Endocrinol Metab 2018;33:55–61, Yu Hyun Kwon et al.)
    Eun-Jung Rhee, Yu Hyun Kwon
    Endocrinology and Metabolism.2018; 33(3): 425.     CrossRef
  • The Association between Persistent Hypertriglyceridemia and the Risk of Diabetes Development: The Kangbuk Samsung Health Study (Endocrinol Metab 2018;33:55–61, Yu Hyun Kwon et al.)
    Mi Hae Seo
    Endocrinology and Metabolism.2018; 33(2): 305.     CrossRef
Close layer
Thyroid
Comparison of Immunohistochemistry and Direct Sanger Sequencing for Detection of the BRAFV600E Mutation in Thyroid Neoplasm
Hye-Seon Oh, Hyemi Kwon, Suyeon Park, Mijin Kim, Min Ji Jeon, Tae Yong Kim, Young Kee Shong, Won Bae Kim, Jene Choi, Won Gu Kim, Dong Eun Song
Endocrinol Metab. 2018;33(1):62-69.   Published online January 30, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.62
  • 5,769 View
  • 68 Download
  • 17 Web of Science
  • 19 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

The BRAFV600E mutation is the most common genetic alteration identified in papillary thyroid carcinoma (PTC). Because of its costs effectiveness and sensitivity, direct Sanger sequencing has several limitations. The aim of this study was to evaluate the efficiency of immunohistochemistry (IHC) as an alternative method to detect the BRAFV600E mutation in preoperative and postoperative tissue samples.

Methods

We evaluated 71 patients who underwent thyroid surgery with the result of direct sequencing of the BRAFV600E mutation. IHC staining of the BRAFV600E mutation was performed in 49 preoperative and 23 postoperative thyroid specimens.

Results

Sixty-two patients (87.3%) had PTC, and of these, BRAFV600E was confirmed by direct sequencing in 57 patients (91.9%). In 23 postoperative tissue samples, the BRAFV600E mutation was detected in 16 samples (70%) by direct sequencing and 18 samples (78%) by IHC. In 24 fine needle aspiration (FNA) samples, BRAFV600E was detected in 18 samples (75%) by direct sequencing and 16 samples (67%) by IHC. In 25 core needle biopsy (CNB) samples, the BRAFV600E mutation was detected in 15 samples (60%) by direct sequencing and 16 samples (64%) by IHC. The sensitivity and specificity of IHC for detecting the BRAFV600E mutation were 77.8% and 66.7% in FNA samples and 99.3% and 80.0% in CNB samples.

Conclusion

IHC could be an alternative method to direct Sanger sequencing for BRAFV600E mutation detection both in postoperative and preoperative samples. However, application of IHC to detect the BRAFV600E mutation in FNA samples is of limited value compared with direct sequencing.

Citations

Citations to this article as recorded by  
  • Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value
    Somayeh Igder, Mozhdeh Zamani, Shima Fakher, Morvarid Siri, Hassan Ashktorab, Negar Azarpira, Pooneh Mokarram, Sowjanya Thatikonda
    Disease Markers.2024; 2024: 1.     CrossRef
  • The Accurate Interpretation and Clinical Significance of Morphological Features of Fine Needle Aspiration Cells in Papillary Thyroid Carcinoma
    Xue-Jiao Xiong, Ming-Ming Xiao, Yi-Xia Zhang, Dong-Ge Liu, Mu-Lan Jin, Jian Wang, Hong-Tao Xu, Qing-Chang Li, Guang-Ping Wu, Giovanni Tuccari
    Analytical Cellular Pathology.2023; 2023: 1.     CrossRef
  • An effective approach for BRAF V600E mutation analysis of routine thyroid fine needle aspirates
    Tanupriya Agrawal, Liqiang Xi, Winnifred Navarro, Mark Raffeld, Snehal B. Patel, Mark J. Roth, Joanna Klubo‐Gwiezdzinska, Armando C. Filie
    Cytopathology.2022; 33(3): 344.     CrossRef
  • A dual identification strategy based on padlock ligation and CRISPR/Cas14a for highly specific detection of BRAF V600E mutation in clinical samples
    Weicheng Shi, Yao Gong, Decai Zhang, Tiantian Yang, Ming Yi, Jingyi Tan, Shijia Ding, Wei Cheng
    Analytical Methods.2022; 14(19): 1913.     CrossRef
  • Research Progress of BRAF V600E Gene Mutation in Papillary Thyroid Carcinoma
    延泽 刘
    Advances in Clinical Medicine.2022; 12(09): 8499.     CrossRef
  • VE1 immunohistochemistry is an adjunct tool for detection of BRAFV600E mutation: Validation in thyroid cancer patients
    Faiza A. Rashid, Sobia Tabassum, Mosin S. Khan, Hifzur R. Ansari, Muhammad Asif, Ahmareen K. Sheikh, Syed Sameer Aga
    Journal of Clinical Laboratory Analysis.2021;[Epub]     CrossRef
  • BRAF testing in a South African cohort of MLH1 deficient endometrial carcinomas: lessons learnt
    Reubina Wadee, Wayne Grayson
    Southern African Journal of Gynaecological Oncology.2021; 13(1): 1.     CrossRef
  • Association between mutation profiles and clinicopathological features in Chinese patients with thyroid cancer
    Changwen Jing, Haixia Cao, Rong Ma, Jianzhong Wu, Zhuo Wang
    Precision Medical Sciences.2021; 10(3): 113.     CrossRef
  • Development of a Molecular Assay for Detection and Quantification of theBRAFVariation in Residual Tissue From Thyroid Nodule Fine-Needle Aspiration Biopsy Specimens
    Guodong Fu, Ronald S. Chazen, Christina MacMillan, Ian J. Witterick
    JAMA Network Open.2021; 4(10): e2127243.     CrossRef
  • Variations in MAP kinase gladiators and risk of differentiated thyroid carcinoma
    Faiza Rashid, Ghulam Bhat, Mosin Khan, Sobia Tabassum, Mohammad Bhat
    Molecular and Clinical Oncology.2021;[Epub]     CrossRef
  • Порівняльне імуногістохімічне дослідження BRAFV600E-позитивних і BRAFV600E-негативних радіогенних і спорадичних папілярних тиреоїдних карцином
    L. Yu. Zurnadzhy, T.I. Rogounovitch, V.O. Saenko, M.Yu. Bolgov, S.V. Masiuk, S.V. Burko, T.L. Degtyaryova, S.V. Chernyshov, S.V. Gulevatyi, N. Mitsutake, M.D. Tronko, T.I. Bogdanova
    Endokrynologia.2021; 26(2): 105.     CrossRef
  • Evaluation of the expression levels of BRAFV600E mRNA in primary tumors of thyroid cancer using an ultrasensitive mutation assay
    Tien Viet Tran, Kien Xuan Dang, Quynh Huong Pham, Ung Dinh Nguyen, Nhung Thi Trang Trinh, Luong Van Hoang, Son Anh Ho, Ba Van Nguyen, Duc Trong Nguyen, Dung Tuan Trinh, Dung Ngoc Tran, Arto Orpana, Ulf-Håkan Stenman, Jakob Stenman, Tho Huu Ho
    BMC Cancer.2020;[Epub]     CrossRef
  • VE1 Immunohistochemistry Improves the Limit of Genotyping for Detecting BRAFV600E Mutation in Papillary Thyroid Cancer
    Sonam Choden, Somboon Keelawat, Chan Kwon Jung, Andrey Bychkov
    Cancers.2020; 12(3): 596.     CrossRef
  • Comparison of Molecular Methods and BRAF Immunohistochemistry (VE1 Clone) for the Detection of BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Meta-Analysis
    Kyle G. Parker, Michael G. White, Nicole A. Cipriani
    Head and Neck Pathology.2020; 14(4): 1067.     CrossRef
  • Next generation sequencing based detection of 15 target genes mutations in papillary thyroid carcinoma
    Zhuo Wang, Changwen Jing, Haixia Cao, SiWen Liu, Jianzhong Wu, Rong Ma
    Precision Medical Sciences.2020; 9(2): 90.     CrossRef
  • A Systematic Review and Meta-Analysis of the Diagnostic Performance of BRAF V600E Immunohistochemistry in Thyroid Histopathology
    Ranjit Singarayer, Ozgur Mete, Laure Perrier, Lehana Thabane, Sylvia L. Asa, Stan Van Uum, Shereen Ezzat, David P. Goldstein, Anna M. Sawka
    Endocrine Pathology.2019; 30(3): 201.     CrossRef
  • Comparison of droplet digital PCR and direct Sanger sequencing for the detection of the BRAFV600E mutation in papillary thyroid carcinoma
    Zhuo Wang, Kejing Sun, Changwen Jing, Haixia Cao, Rong Ma, Jianzhong Wu
    Journal of Clinical Laboratory Analysis.2019;[Epub]     CrossRef
  • Immunohistochemistry Innovations for Diagnosis and Tissue-Based Biomarker Detection
    Narittee Sukswai, Joseph D. Khoury
    Current Hematologic Malignancy Reports.2019; 14(5): 368.     CrossRef
  • Immunohistochemistry is a feasible method to screen BRAF V600E mutation in colorectal and papillary thyroid carcinoma
    Xiangyan Zhang, Lili Wang, Jigang Wang, Han Zhao, Jie Wu, Shuhong Liu, Lu Zhang, Yujun Li, Xiaoming Xing
    Experimental and Molecular Pathology.2018; 105(1): 153.     CrossRef
Close layer
Thyroid
Validity and Reliability of the Korean Version of the Hyperthyroidism Symptom Scale
Jie-Eun Lee, Dong Hwa Lee, Tae Jung Oh, Kyoung Min Kim, Sung Hee Choi, Soo Lim, Young Joo Park, Do Joon Park, Hak Chul Jang, Jae Hoon Moon
Endocrinol Metab. 2018;33(1):70-78.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.70
  • 4,002 View
  • 54 Download
  • 3 Web of Science
  • 3 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Thyrotoxicosis is a common disease resulting from an excess of thyroid hormones, which affects many organ systems. The clinical symptoms and signs are relatively nonspecific and can vary depending on age, sex, comorbidities, and the duration and cause of the disease. Several symptom rating scales have been developed in an attempt to assess these symptoms objectively and have been applied to diagnosis or to evaluation of the response to treatment. The aim of this study was to assess the reliability and validity of the Korean version of the hyperthyroidism symptom scale (K-HSS).

Methods

Twenty-eight thyrotoxic patients and 10 healthy subjects completed the K-HSS at baseline and after follow-up at Seoul National University Bundang Hospital. The correlation between K-HSS scores and thyroid function was analyzed. K-HSS scores were compared between baseline and follow-up in patient and control groups. Cronbach's α coefficient was calculated to demonstrate the internal consistency of K-HSS.

Results

The mean age of the participants was 34.7±9.8 years and 13 (34.2%) were men. K-HSS scores demonstrated a significant positive correlation with serum free thyroxine concentration and decreased significantly with improved thyroid function. K-HSS scores were highest in subclinically thyrotoxic subjects, lower in patients who were euthyroid after treatment, and lowest in the control group at follow-up, but these differences were not significant. Cronbach's α coefficient for the K-HSS was 0.86.

Conclusion

The K-HSS is a reliable and valid instrument for evaluating symptoms of thyrotoxicosis in Korean patients.

Citations

Citations to this article as recorded by  
  • Effect of thyroid-stimulating hormone suppression on quality of life in thyroid lobectomy patients: interim analysis of a multicenter, randomized controlled trial in low- to intermediate-risk thyroid cancer patients (MASTER study)
    Ja Kyung Lee, Eu Jeong Ku, Su-jin Kim, Woochul Kim, Jae Won Cho, Kyong Yeun Jung, Hyeong Won Yu, Yea Eun Kang, Mijin Kim, Hee Kyung Kim, Junsun Ryu, June Young Choi
    Annals of Surgical Treatment and Research.2024; 106(1): 19.     CrossRef
  • Effect of increased levothyroxine dose on depressive mood in older adults undergoing thyroid hormone replacement therapy
    Jae Hoon Moon, Ji Won Han, Tae Jung Oh, Sung Hee Choi, Soo Lim, Ki Woong Kim, Hak Chul Jang
    Clinical Endocrinology.2020; 93(2): 196.     CrossRef
  • Clinical Feasibility of Monitoring Resting Heart Rate Using a Wearable Activity Tracker in Patients With Thyrotoxicosis: Prospective Longitudinal Observational Study
    Jie-Eun Lee, Dong Hwa Lee, Tae Jung Oh, Kyoung Min Kim, Sung Hee Choi, Soo Lim, Young Joo Park, Do Joon Park, Hak Chul Jang, Jae Hoon Moon
    JMIR mHealth and uHealth.2018; 6(7): e159.     CrossRef
Close layer
Diabetes
Association between White Blood Cell Counts within Normal Range and Hemoglobin A1c in a Korean Population
Jae Won Hong, Jung Hyun Noh, Dong-Jun Kim
Endocrinol Metab. 2018;33(1):79-87.   Published online January 30, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.79
  • 4,551 View
  • 50 Download
  • 5 Web of Science
  • 6 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

We examined whether white blood cell (WBC) count levels within normal range, could be associated with hemoglobin A1c (HbA1c) levels.

Methods

Among the 11,472 people (≥19 years of age) who participated in the 2011 to 2012 Korea National Health and Nutrition Examination, subjects with chronic disease or illness, including 807 patients with diabetes currently taking anti-diabetic medications and/or 1,149 subjects with WBC levels <4,000 or >10,000/µL were excluded.

Results

Overall, adjusted HbA1c levels increased across the WBC quartiles (5.55%±0.01%, 5.58%±0.01%, 5.60%±0.01%, and 5.65%±0.01%, P<0.001) after adjusting for confounding factors, such as age, gender, fasting plasma glucose, college graduation, smoking history, waist circumference, presence of hypertension, serum total cholesterol, serum triglyceride, and presence of anemia. The adjusted proportions (%) of HbA1c levels of ≥5.7%, ≥6.1%, and ≥6.5% showed significant increases across WBC quartiles (P<0.001, P=0.002, and P=0.022, respectively). Logistic regression analyses of WBC quartiles for the risk of HbA1c levels of ≥5.7%, ≥6.1%, and ≥6.5%, using the variables above as covariates, showed that the odds ratios of the fourth quartile of WBCs were 1.59 (95% confidence interval [CI], 1.35 to 1.89; P<0.001), 1.78 (95% CI, 1.31 to 2.42; P<0.001), and 2.03 (95% CI, 1.13 to 3.64; P=0.018), using the first quartile of WBCs as the reference.

Conclusion

HbA1c levels were positively associated with WBC levels within normal range in a general adult population.

Citations

Citations to this article as recorded by  
  • Vitamin D supplementation modulates glycated hemoglobin (HBA1c) in diabetes mellitus
    Asma Akhter, Sultan Alouffi, Uzma Shahab, Rihab Akasha, Mohd Fazal-Ur-Rehman, Mohamed E. Ghoniem, Naved Ahmad, Kirtanjot Kaur, Ramendra Pati Pandey, Ahmed Alshammari, Firoz Akhter, Saheem Ahmad
    Archives of Biochemistry and Biophysics.2024; 753: 109911.     CrossRef
  • Glucose indices as inflammatory markers in children with acute surgical abdomen: a cross-sectional study
    Hoda Atef Abdelsattar Ibrahim, Sherif Kaddah, Sara Mohamed Elkhateeb, Abeer Aboalazayem, Aya Ahmed Amin, Mahmoud Marei Marei
    Annals of Medicine.2023;[Epub]     CrossRef
  • Factors associated with relative muscle strength in patients with type 2 diabetes mellitus
    Chiao-Nan Chen, Ting-Chung Chen, Shiow-Chwen Tsai, Chii-Min Hwu
    Archives of Gerontology and Geriatrics.2021; 95: 104384.     CrossRef
  • Non-vascular contributing factors of diabetic foot ulcer severity in national referral hospital of Indonesia
    Em Yunir, Dicky L. Tahapary, Tri Juli Edi Tarigan, Dante Saksono Harbuwono, Yoga Dwi Oktavianda, Melly Kristanti, Eni Iswati, Angela Sarumpaet, Pradana Soewondo
    Journal of Diabetes & Metabolic Disorders.2021; 20(1): 805.     CrossRef
  • Association between Inflammatory Markers and Glycemic Control in Korean Diabetic Patients
    Min Kang, Seok-Joon Sohn
    Journal of Health Informatics and Statistics.2021; 46(3): 247.     CrossRef
  • Prediabetes Is Independently Associated with Subclinical Carotid Atherosclerosis: An Observational Study in a Non-Urban Mediterranean Population
    Maria Belén Vilanova, Josep Franch-Nadal, Mireia Falguera, Josep Ramon Marsal, Sílvia Canivell, Esther Rubinat, Neus Miró, Àngels Molló, Manel Mata-Cases, Mònica Gratacòs, Esmeralda Castelblanco, Dídac Mauricio
    Journal of Clinical Medicine.2020; 9(7): 2139.     CrossRef
Close layer
Diabetes
High Brachial Ankle Pulse Wave Velocity as a Marker for Predicting Coronary Artery Stenosis in Patients with Type 2 Diabetes
Bo Hyun Kim, Jae Sik Jang, Yong Seop Kwon, June Hyung Kim, In Joo Kim, Chang Won Lee
Endocrinol Metab. 2018;33(1):88-96.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.88
  • 4,414 View
  • 54 Download
  • 13 Web of Science
  • 14 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

We evaluated the ability of brachial ankle pulse wave velocity (baPWV) to predict coronary artery stenosis (CAS) in patients with type 2 diabetes, and compared the predictive power of baPWV to that of well-known cardiovascular disease (CVD) risk calculators.

Methods

The study group included 83 consecutive patients over 30 years old with type 2 diabetes who complained of vague chest discomfort. An automatic pulse waveform analyzer was used to measure baPWV. CAS was measured using multi-slice computed tomographic (MSCT) angiography.

Results

Age, maximal baPWV, duration of diabetes, current smoking, the UK Prospective Diabetes Study (UKPDS) Risk Engine score, American College of Cardiology/American Heart Association (ACC/AHA) risk estimator score, the Framingham risk calculator score, and coronary artery calcium score were greater in patients with CAS than in those without CAS. An area under the curve (AUC) indicative of a predictive value for CAS (≥20%) was found for several parameters. The AUC of maximal baPWV, the UKPDS Risk Engine, the ACC/AHA ASCVD risk estimator, and the Framingham risk calculator were 0.672 (95% confidence interval [CI], 0.554 to 0.785; P=0.010), 0.777 (95% CI, 0.675 to 0.878; P<0.001), 0.763 (95% CI, 0.660 to 0.866; P<0.001), and 0.736 (95% CI, 0.629 to 0.843; P<0.001), respectively. The optimal cutoff value of baPWV for the detection of CAS was 1,650 cm/sec (sensitivity, 68.9%; specificity, 63.2%).

Conclusion

Maximal baPWV was closely related with CAS detected by MSCT coronary angiography in patients with type 2 diabetes. baPWV has the potential to be a useful, noninvasive screening tool for the prediction of occult CAS in patients with type 2 diabetes.

Citations

Citations to this article as recorded by  
  • Polyvinyl Alcohol Phantoms With Heterogeneous Plaques: Estimation of Pulse Wave Velocity at the Stenotic Region Using Pulse Wave Imaging
    Nima Mobadersany, Pengcheng Liang, Paul Kemper, Elisa E. Konofagou
    Ultrasound in Medicine & Biology.2024; 50(1): 91.     CrossRef
  • The risk factors of early arterial stiffness in type 2 diabetes without diabetic macroangiopathy
    Jia-Hui Wu, Rui Wang, Xiao-Jiao Jia, Na Lu, Qiang Lu, Fu-Zai Yin, Chun-Ming Ma
    International Journal of Diabetes in Developing Countries.2023;[Epub]     CrossRef
  • Arterial Stiffness as a Predictor of the Index of Atherosclerotic Cardiovascular Disease in Hypertensive Patients
    Guili Chang, Yueliang Hu, Qian Ge, Shaoli Chu, Alberto Avolio, Junli Zuo
    International Journal of Environmental Research and Public Health.2023; 20(4): 2832.     CrossRef
  • Pulse wave imaging of a stenotic artery model with plaque constituents of different stiffnesses: Experimental demonstration in phantoms and fluid-structure interaction simulation
    Nima Mobadersany, Nirvedh H. Meshram, Paul Kemper, C.V. Sise, Grigorios M. Karageorgos, Pengcheng Liang, Gerard A. Ateshian, Elisa E. Konofagou
    Journal of Biomechanics.2023; 149: 111502.     CrossRef
  • Computational clustering reveals differentiated coronary artery calcium progression at prevalent levels of pulse wave velocity by classifying high-risk patients
    Maximo Rousseau-Portalis, Leandro Cymberknop, Ignacio Farro, Ricardo Armentano
    Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
  • Pepsinogen ratio and brachial-ankle pulse wave velocity: a cross-sectional study on their interrelationship in atherosclerosis
    Yuexi Li, Xiaoqin Liu, Yuhan Luo, Qiaoli Wang
    BMC Cardiovascular Disorders.2023;[Epub]     CrossRef
  • The Plasma Atherogenic Index is an Independent Predictor of Arterial Stiffness in Healthy Koreans
    Ji Sun Nam, Min Kyung Kim, Kahui Park, Arim Choi, Shinae Kang, Chul Woo Ahn, Jong Suk Park
    Angiology.2022; 73(6): 514.     CrossRef
  • Risk assessment indicators and brachial-ankle pulse wave velocity to predict atherosclerotic cardiovascular disease
    Hung-Ju Ko, Chuan-Chuan Liu, Po-Jui Hsu, Kuang-Chun Hu, Chung-Lieh Hung, Lo-Yip Yu, Yun-Chieh Huang, Shou-Chuan Shih
    Medicine.2022; 101(32): e29609.     CrossRef
  • Brachial-ankle pulse wave velocity as a predictor of long-term cardiovascular events in 2174 subjects with type 2 diabetes mellitus: A retrospective cohort study
    Hack-Lyoung Kim, Won Kyeong Jeon, Hyun Sung Joh, Woo-Hyun Lim, Jae-Bin Seo, Sang-Hyun Kim, Joo-Hee Zo, Myung-A Kim
    Medicine.2022; 101(45): e31758.     CrossRef
  • Ultrasound Methods in the Evaluation of Atherosclerosis: From Pathophysiology to Clinic
    Gabriel Cismaru, Teodora Serban, Alexandru Tirpe
    Biomedicines.2021; 9(4): 418.     CrossRef
  • A model to predict risk of stroke in middle-aged adults with type 2 diabetes generated from a nationwide population-based cohort study in Korea
    Mee-Kyoung Kim, Kyungdo Han, Jae-Hyoung Cho, Hyuk-Sang Kwon, Kun-Ho Yoon, Seung-Hwan Lee
    Diabetes Research and Clinical Practice.2020; 163: 108157.     CrossRef
  • Association of impaired arterial wall properties with the presence of coronary artery disease in patients with abdominal aortic aneurysms
    Pinelopi Rafouli‐Stergiou, Ignatios Ikonomidis, Niki Katsiki, Nikolaos P. E. Kadoglou, Stefanos Vlachos, John Thymis, John Parissis, Konstantinos G. Moulakakis, John D. Kakisis
    The Journal of Clinical Hypertension.2020; 22(2): 187.     CrossRef
  • Association of serum FAM19A5 with metabolic and vascular risk factors in human subjects with or without type 2 diabetes
    You-Bin Lee, Hwan-Jin Hwang, Jung A Kim, Soon Young Hwang, Eun Roh, So-hyeon Hong, Kyung Mook Choi, Sei Hyun Baik, Hye Jin Yoo
    Diabetes and Vascular Disease Research.2019; 16(6): 530.     CrossRef
  • Pulse Wave Velocity in Atherosclerosis
    Hack-Lyoung Kim, Sang-Hyun Kim
    Frontiers in Cardiovascular Medicine.2019;[Epub]     CrossRef
Close layer
Miscellaneous
Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer
Ji-Yeon Lee, Namki Hong, Hye Ryun Kim, Byung Wan Lee, Eun Seok Kang, Bong-Soo Cha, Yong-ho Lee
Endocrinol Metab. 2018;33(1):97-104.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.97
  • 4,377 View
  • 44 Download
  • 8 Web of Science
  • 5 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

A recent animal study showed that parathyroid hormone-related peptide (PTHrP) is associated with cancer cachexia by promoting adipose tissue browning, and we previously demonstrated that PTHrP predicts weight loss (WL) in patients with cancer. In this study, we investigated whether prediction of WL by PTHrP is influenced by clinical factors such as serum albumin, corrected calcium levels, cancer stage, and performance status (PS).

Methods

A cohort of 219 patients with cancer whose PTHrP level was measured was enrolled and followed for body weight (BW) changes. Subjects were divided into two groups by serum albumin (cutoff value, 3.7 g/dL), corrected calcium (cutoff value, 10.5 mg/dL), cancer stage (stage 1 to 3 or 4), or PS (Eastern Cooperative Oncology Group 0 to 1 or 2 to 4), respectively. Clinically significant WL was defined as either percent of BW change (% BW) <−5% or % BW <−2% plus body mass index (BMI) <20 kg/m2.

Results

After a median follow-up of 327 days, 74 patients (33.8%) experienced clinically significant WL. A positive PTHrP level was associated with a 2-fold increased risk of WL after adjusting for age, baseline BMI, serum albumin, corrected calcium level, cancer stage, and PS. The effect of PTHrP on WL remained significant in patients with low serum albumin, stage 4 cancer, and good PS. Regardless of calcium level, the effect of PTHrP on WL was maintained, although there was an additive effect of higher calcium and PTHrP levels.

Conclusion

Early recognition of patients with advanced cancer who are PTHrP positive with hypercalcemia or hypoalbuminemia is needed for their clinical management.

Citations

Citations to this article as recorded by  
  • Can Patients with Electrolyte Disturbances Be Safely and Effectively Treated in a Hospital-at-Home, Telemedicine-Controlled Environment? A Retrospective Analysis of 267 Patients
    Cohn May, Gueron Or, Segal Gad, Zubli Daniel, Hakim Hila, Fizdel Boris, Liber Pninit, Amir Hadar, Barkai Galia
    Journal of Clinical Medicine.2024; 13(5): 1409.     CrossRef
  • Parathyroid hormone related protein (PTHrP) in patients with pancreatic carcinoma and overt signs of disease progression and host tissue wasting
    Britt-Marie Iresjö, Serkan Kir, Kent Lundholm
    Translational Oncology.2023; 36: 101752.     CrossRef
  • Development and Characterization of a Cancer Cachexia Rat Model Transplanted with Cells of the Rat Lung Adenocarcinoma Cell Line Sato Lung Cancer (SLC)
    Eiji Kasumi, Miku Chiba, Yoshie Kuzumaki, Hiroyuki Kuzuoka, Norifumi Sato, Banyu Takahashi
    Biomedicines.2023; 11(10): 2824.     CrossRef
  • Inhibition of epidermal growth factor receptor suppresses parathyroid hormone‐related protein expression in tumours and ameliorates cancer‐associated cachexia
    Bahar Zehra Camurdanoglu Weber, Samet Agca, Aylin Domaniku, Sevval Nur Bilgic, Dilsad H. Arabaci, Serkan Kir
    Journal of Cachexia, Sarcopenia and Muscle.2022; 13(3): 1582.     CrossRef
  • Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia
    Bahar Zehra Camurdanoglu Weber, Dilsad H. Arabaci, Serkan Kir
    Frontiers in Oncology.2022;[Epub]     CrossRef
Close layer
Diabetes
Pioglitazone Attenuates Palmitate-Induced Inflammation and Endoplasmic Reticulum Stress in Pancreatic β-Cells
Seok-Woo Hong, Jinmi Lee, Jung Hwan Cho, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee
Endocrinol Metab. 2018;33(1):105-113.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.105
  • 6,210 View
  • 95 Download
  • 19 Web of Science
  • 23 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

The nuclear receptor peroxisome proliferator-activator gamma (PPARγ) is a useful therapeutic target for obesity and diabetes, but its role in protecting β-cell function and viability is unclear.

Methods

To identify the potential functions of PPARγ in β-cells, we treated mouse insulinoma 6 (MIN6) cells with the PPARγ agonist pioglitazone in conditions of lipotoxicity, endoplasmic reticulum (ER) stress, and inflammation.

Results

Palmitate-treated cells incubated with pioglitazone exhibited significant improvements in glucose-stimulated insulin secretion and the repression of apoptosis, as shown by decreased caspase-3 cleavage and poly (adenosine diphosphate [ADP]-ribose) polymerase activity. Pioglitazone also reversed the palmitate-induced expression of inflammatory cytokines (tumor necrosis factor α, interleukin 6 [IL-6], and IL-1β) and ER stress markers (phosphor-eukaryotic translation initiation factor 2α, glucose-regulated protein 78 [GRP78], cleaved-activating transcription factor 6 [ATF6], and C/EBP homologous protein [CHOP]), and pioglitazone significantly attenuated inflammation and ER stress in lipopolysaccharide- or tunicamycin-treated MIN6 cells. The protective effect of pioglitazone was also tested in pancreatic islets from high-fat-fed KK-Ay mice administered 0.02% (wt/wt) pioglitazone or vehicle for 6 weeks. Pioglitazone remarkably reduced the expression of ATF6α, GRP78, and monocyte chemoattractant protein-1, prevented α-cell infiltration into the pancreatic islets, and upregulated glucose transporter 2 (Glut2) expression in β-cells. Moreover, the preservation of β-cells by pioglitazone was accompanied by a significant reduction of blood glucose levels.

Conclusion

Altogether, these results support the proposal that PPARγ agonists not only suppress insulin resistance, but also prevent β-cell impairment via protection against ER stress and inflammation. The activation of PPARγ might be a new therapeutic approach for improving β-cell survival and insulin secretion in patients with diabetes mellitus

Citations

Citations to this article as recorded by  
  • Nr1h4 and Thrb ameliorate ER stress and provide protection in the MPTP mouse model of Parkinson’s
    Nancy Ahuja, Shalini Gupta, Rashmi Arora, Ella Bhagyaraj, Drishti Tiwari, Sumit Kumar, Pawan Gupta
    Life Science Alliance.2024; 7(7): e202302416.     CrossRef
  • Prosthetic vascular grafts engineered to combat calcification: Progress and future directions
    Taylor K. Brown, Sara Alharbi, Karen J. Ho, Bin Jiang
    Biotechnology and Bioengineering.2023; 120(4): 953.     CrossRef
  • Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023
    Harold Edward Bays, Shagun Bindlish, Tiffany Lowe Clayton
    Obesity Pillars.2023; 5: 100056.     CrossRef
  • Metformin promotes osteogenic differentiation and prevents hyperglycaemia-induced osteoporosis by suppressing PPARγ expression
    Lifeng Zheng, Ximei Shen, Yun Xie, Hong Lian, Sunjie Yan, Shizhong Wang
    Acta Biochimica et Biophysica Sinica.2023; 55(3): 394.     CrossRef
  • Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas
    Henrique Souza-Tavares, Carolline Santos Miranda, Isabela Macedo Lopes Vasques-Monteiro, Cristian Sandoval, Daiana Araujo Santana-Oliveira, Flavia Maria Silva-Veiga, Aline Fernandes-da-Silva, Vanessa Souza-Mello
    World Journal of Gastroenterology.2023; 29(26): 4136.     CrossRef
  • Nicotinamide N-methyltransferase upregulation contributes to palmitate-elicited peroxisome proliferator-activated receptor transactivation in hepatocytes
    Qing Song, Jun Wang, Alexandra Griffiths, Samuel Man Lee, Iredia D. Iyamu, Rong Huang, Jose Cordoba-Chacon, Zhenyuan Song
    American Journal of Physiology-Cell Physiology.2023; 325(1): C29.     CrossRef
  • The global perspective on peroxisome proliferator-activated receptor γ (PPARγ) in ectopic fat deposition: A review
    Yanhao Qiu, Mailin Gan, Xingyu Wang, Tianci Liao, Qiuyang Chen, Yuhang Lei, Lei Chen, Jinyong Wang, Ye Zhao, Lili Niu, Yan Wang, Shunhua Zhang, Li Zhu, Linyuan Shen
    International Journal of Biological Macromolecules.2023; 253: 127042.     CrossRef
  • Chemical inducer of regucalcin attenuates lipopolysaccharide‐induced inflammatory responses in pancreatic MIN6 β‐cells and RAW264.7 macrophages
    Tomiyasu Murata, Kazunori Hashimoto, Susumu Kohno, Chiaki Takahashi, Masayoshi Yamaguchi, Chihiro Ito, Itoigawa Masataka, Roji Kojima, Kiyomi Hikita, Norio Kaneda
    FEBS Open Bio.2022; 12(1): 175.     CrossRef
  • Targets for rescue from fatty acid-induced lipotoxicity in pancreatic beta cells
    Seok-Woo Hong, Won-Young Lee
    Cardiovascular Prevention and Pharmacotherapy.2022; 4(2): 57.     CrossRef
  • Analysis of changes in the proteomic profile of porcine corpus luteum during different stages of the oestrous cycle: effects of PPAR gamma ligands
    Zuzanna Kunicka, Karol Mierzejewski, Aleksandra Kurzyńska, Robert Stryiński, Jesús Mateos, Mónica Carrera, Monika Golubska, Iwona Bogacka, Xiaolong Wang
    Reproduction, Fertility and Development.2022; 34(11): 776.     CrossRef
  • Activation of PPARγ Protects Obese Mice from Acute Lung Injury by Inhibiting Endoplasmic Reticulum Stress and Promoting Mitochondrial Biogenesis
    Yin Tang, Ke Wei, Ling Liu, Jingyue Ma, Siqi Wu, Wenjing Tang, Stéphane Mandard
    PPAR Research.2022; 2022: 1.     CrossRef
  • Effect of Pioglitazone on endoplasmic reticulum stress regarding in situ perfusion rat model
    Vivien Telek, Luca Erlitz, Ibitamuno Caleb, Tibor Nagy, Mónika Vecsernyés, Bálint Balogh, György Sétáló, Péter Hardi, Gábor Jancsó, Ildikó Takács
    Clinical Hemorheology and Microcirculation.2021; 79(2): 311.     CrossRef
  • Inflammation in Metabolic Diseases and Insulin Resistance
    Won-Young Lee
    Cardiovascular Prevention and Pharmacotherapy.2021; 3(2): 31.     CrossRef
  • Current Status of Endoplasmic Reticulum Stress in Type II Diabetes
    Sagir Mustapha, Mustapha Mohammed, Ahmad Khusairi Azemi, Abubakar Ibrahim Jatau, Aishatu Shehu, Lukman Mustapha, Ibrahim Muazzamu Aliyu, Rabi’u Nuhu Danraka, Abdulbasit Amin, Auwal Adam Bala, Wan Amir Nizam Wan Ahmad, Aida Hanum Ghulam Rasool, Mohd Rais M
    Molecules.2021; 26(14): 4362.     CrossRef
  • JunD Regulates Pancreatic β-Cells Function by Altering Lipid Accumulation
    Kexin Wang, Yixin Cui, Peng Lin, Zhina Yao, Yu Sun
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial
    Giuseppe Della Pepa, Marco Russo, Marilena Vitale, Fabrizia Carli, Claudia Vetrani, Maria Masulli, Gabriele Riccardi, Olga Vaccaro, Amalia Gastaldelli, Angela A. Rivellese, Lutgarda Bozzetto
    Diabetes Research and Clinical Practice.2021; 178: 108984.     CrossRef
  • Radioprotective Effect of Pioglitazone Against Genotoxicity Induced by Ionizing Radiation in Healthy Human Lymphocytes
    Roya Kazemi, Seyed J. Hosseinimehr
    Cardiovascular & Hematological Agents in Medicinal Chemistry .2021; 19(1): 72.     CrossRef
  • Recent Insights Into Mechanisms of β-Cell Lipo- and Glucolipotoxicity in Type 2 Diabetes
    Maria Lytrivi, Anne-Laure Castell, Vincent Poitout, Miriam Cnop
    Journal of Molecular Biology.2020; 432(5): 1514.     CrossRef
  • Artemisinin and dihydroartemisinin promote β-cell apoptosis induced by palmitate via enhancing ER stress
    Ke Chen, Hu Hua, Ziyang Zhu, Tong Wu, Zhanjun Jia, Qianqi Liu
    Apoptosis.2020; 25(3-4): 192.     CrossRef
  • Mechanisms of impaired pancreatic β‑cell function in high‑fat diet‑induced obese mice: The role of endoplasmic reticulum stress
    Xiaoqing Yi, Xuan Cai, Sisi Wang, Yanfeng Xiao
    Molecular Medicine Reports.2020;[Epub]     CrossRef
  • Docosahexaenoic and Eicosapentaenoic Acids Prevent Altered-Muc2 Secretion Induced by Palmitic Acid by Alleviating Endoplasmic Reticulum Stress in LS174T Goblet Cells
    Quentin Escoula, Sandrine Bellenger, Michel Narce, Jérôme Bellenger
    Nutrients.2019; 11(9): 2179.     CrossRef
  • PPAR-γ agonist, pioglitazone, reduced oxidative and endoplasmic reticulum stress associated with L-NAME-induced hypertension in rats
    Eman Soliman, Shereen F. Behairy, Nabila N. El-maraghy, Shimaa M. Elshazly
    Life Sciences.2019; 239: 117047.     CrossRef
  • Changes of MODY signal pathway genes in the endoplasmic reticulum stress in INS-1-3 cells
    Yanan Dong, Shirui Li, Wenhui Zhao, Yanlei Wang, Tingting Ge, Jianzhong Xiao, Yukun Li, Herve Le Stunff
    PLOS ONE.2018; 13(6): e0198614.     CrossRef
Close layer
Thyroid
A Comparison of Ultrasound-Guided Fine Needle Aspiration versus Core Needle Biopsy for Thyroid Nodules: Pain, Tolerability, and Complications
Eun Ji Jeong, Sae Rom Chung, Jung Hwan Baek, Young Jun Choi, Jae Kyun Kim, Jeong Hyun Lee
Endocrinol Metab. 2018;33(1):114-120.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.114
  • 5,337 View
  • 60 Download
  • 24 Web of Science
  • 22 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

To compare pain, tolerability, and complications associated with fine needle aspiration (FNA) versus core needle biopsy (CNB).

Methods

FNAs were performed using 23-gauge needles and CNBs were performed using 18-gauge double-action spring-activated needles in 100 patients for each procedure. Patients were asked to record a pain score using a 10-cm visual analog scale and procedure tolerability. Complications and number of biopsies were recorded.

Results

The median pain scores were similar for the FNA and CNB approaches during and 20 minutes after the biopsy procedures (3.7 vs. 3.6, P=0.454; 0.9 vs. 1.1, P=0.296, respectively). The procedure was tolerable in all 100 FNA patients and in 97 CNB patients (P=0.246). The mean number of biopsies was fewer in the CNB group (1.4 vs. 1.2, P=0.002). By subgroup analysis (staff vs. non-staff), no significant difference was detected in any parameter. There were no major complications in either group, but three patients who underwent CNB had minor complications (P=0.246).

Conclusion

FNA and CNB show no significant differences for diagnosing thyroid nodules in terms of pain, tolerability, or complications.

Citations

Citations to this article as recorded by  
  • A comparative analysis of core needle biopsy and repeat fine needle aspiration in patients with inconclusive initial cytology of thyroid nodules
    Xuejiao Su, Can Yue, Wanting Yang, Buyun Ma
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Assessing Adequacy: A Meta-Analysis of Rapid Onsite Evaluation of Thyroid Nodules
    Peter P. Issa, Christina McCarthy, Mohammad Hussein, Aaron L. Albuck, Essam Emad, Mohamed Shama, Krzysztof Moroz, Eman Toraih, Emad Kandil
    Journal of Surgical Research.2024; 296: 523.     CrossRef
  • Histology-based and cytology-based needle sampling for targeted next-generation sequencing in the indeterminate thyroid tumors
    Chun-Nan Chen, Tsung-Lin Yang
    European Archives of Oto-Rhino-Laryngology.2023; 280(8): 3773.     CrossRef
  • Preoperative evaluation of thyroid nodules – Diagnosis and management strategies
    Tapoi Dana Antonia, Lambrescu Ioana Maria, Gheorghisan-Galateanu Ancuta-Augustina
    Pathology - Research and Practice.2023; 246: 154516.     CrossRef
  • Keloid Development After Fine Needle Aspiration of the Thyroid: A Rare Case and Review of Management Strategies
    Shaniah S Holder, Alaerebo S Malvan-iyalla, Sara Arfan, Vimal Basani, Frederick Tiesenga
    Cureus.2023;[Epub]     CrossRef
  • Utilidad de la biopsia con aguja gruesa ecoguiada en nódulos tiroideos con punción aspirativa con aguja fina no diagnóstica
    R. Cortázar-García, M.D. Martín-Escalante, L. Robles-Cabeza, C. Martínez-Santos
    Radiología.2022; 64(3): 195.     CrossRef
  • Thyroid diagnostic modalities (fine needle aspiration and core needle biopsy) with histology correlation: a tertiary centre experience
    Sona J Appukutty, Anna Paterson, Nishant S Patel, Adam Duckworth, James Chan, Maria O'Donovan, Alison J Marker
    Journal of Clinical Pathology.2022; 75(9): 620.     CrossRef
  • Diagnostic performance of core needle biopsy for nodal recurrences in patients with head and neck squamous cell carcinoma
    Ta-Hsuan Lo, Cheng-Ping Wang, Chun-Nan Chen, Tsung-Lin Yang, Pei-Jen Lou, Jenq-Yuh Ko, Yih-Leong Chang, Tseng-Cheng Chen
    Scientific Reports.2022;[Epub]     CrossRef
  • The efficacy of incorporating ultrasound-guided core biopsy into the clinical workflow of indeterminate thyroid tumors
    Chun-Nan Chen, Min-Shu Hsieh, Yi-Hsuan Lee, Tsung-Lin Yang
    Journal of the Formosan Medical Association.2022; 121(10): 2012.     CrossRef
  • A Literature Review of Factors Associated With Pain From Fine Needle Aspiration Biopsy of Thyroid Nodules
    Tao Liu, Manisha Tilak, Sara Awad, Joshua Lakoff
    Endocrine Practice.2022; 28(6): 628.     CrossRef
  • Usefulness of ultrasound-guided core biopsy in thyroid nodules with inconclusive fine-needle aspiration biopsy findings
    R. Cortázar-García, M.D. Martín-Escalante, L. Robles-Cabeza, C. Martínez-Santos
    Radiología (English Edition).2022; 64(3): 195.     CrossRef
  • Permanent vocal fold paralysis after ultrasound-guided core needle biopsy of thyroid nodule
    Kathrin Zimmerman, Matthew Hoffman, Amalee Smith, C. Blake Simpson
    Otolaryngology Case Reports.2022; 24: 100455.     CrossRef
  • Interobserver variability in ultrasound assessment of thyroid nodules
    Jaber Alyami, Fahad F. Almutairi, Sultan Aldoassary, Amani Albeshry, Ali Almontashri, Mazen Abounassif, Majed Alamri
    Medicine.2022; 101(41): e31106.     CrossRef
  • Usage and Diagnostic Yield of Fine-Needle Aspiration Cytology and Core Needle Biopsy in Thyroid Nodules: A Systematic Review and Meta-Analysis of Literature Published by Korean Authors
    Soon-Hyun Ahn
    Clinical and Experimental Otorhinolaryngology.2021; 14(1): 116.     CrossRef
  • Hydrodissection: A Novel Approach for Safe Core Needle Biopsy of Small High-Risk Subcapsular Thyroid Nodules
    Hojat Ebrahiminik, Hossein Chegeni, Javad Jalili, Rambod Salouti, Hadi Rokni, Afshin Mohammadi, Ali Mosaddegh Khah, Seyed Mohammad Tavangar, Zahra Ebrahiminik
    CardioVascular and Interventional Radiology.2021; 44(10): 1651.     CrossRef
  • A Blinded Randomized Trial Comparing 2 Needle Gauges for Fine‐Needle Biopsy of Thyroid Nodules
    Christopher M. Shumrick, Jonathan C. Simmonds, Lorna L. Ogden, Cindi A. Snowden, Jagdish K. Dhingra
    OTO Open.2021;[Epub]     CrossRef
  • Application of biomarkers in the diagnosis of uncertain samples of core needle biopsy of thyroid nodules
    Yan Xiong, Xin Li, Li Liang, Dong Li, Limin Yan, Xueying Li, Jiting Di, Ting Li
    Virchows Archiv.2021; 479(5): 961.     CrossRef
  • Diagnostic Efficacy and Safety of Core Needle Biopsy as a First-Line Diagnostic Method for Thyroid Nodules: A Prospective Cohort Study
    Min Ji Hong, Dong Gyu Na, Hunkyung Lee
    Thyroid.2020; 30(8): 1141.     CrossRef
  • Comparison Between Fine Needle Aspiration and Core Needle Biopsy for the Diagnosis of Thyroid Nodules: Effective Indications According to US Findings
    Soo Yeon Hahn, Jung Hee Shin, Young Lyun Oh, Ko Woon Park, Yaeji Lim
    Scientific Reports.2020;[Epub]     CrossRef
  • 2019 Practice guidelines for thyroid core needle biopsy: a report of the Clinical Practice Guidelines Development Committee of the Korean Thyroid Association
    Chan Kwon Jung, Jung Hwan Baek, Dong Gyu Na, Young Lyun Oh, Ka Hee Yi, Ho-Cheol Kang
    Journal of Pathology and Translational Medicine.2020; 54(1): 64.     CrossRef
  • Pathological diagnosis of thyroid nodules based on core needle biopsies: comparative study between core needle biopsies and resected specimens in 578 cases
    Yan Xiong, Limin Yan, Lin Nong, Yalin Zheng, Ting Li
    Diagnostic Pathology.2019;[Epub]     CrossRef
  • The Significance of Having an Excellent Patient's Comfort with Thyroid Core Needle Biopsy
    Pierpaolo Trimboli, Luca Giovanella
    Endocrinology and Metabolism.2018; 33(1): 53.     CrossRef
Close layer
Thyroid
Combined Effects of Baicalein and Docetaxel on Apoptosis in 8505c Anaplastic Thyroid Cancer Cells via Downregulation of the ERK and Akt/mTOR Pathways
Chan Ho Park, Se Eun Han, Il Seong Nam-Goong, Young Il Kim, Eun Sook Kim
Endocrinol Metab. 2018;33(1):121-132.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.121
  • 4,956 View
  • 62 Download
  • 41 Web of Science
  • 35 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Anaplastic thyroid cancer (ATC) is one of the most lethal human malignancies. Docetaxel, a microtubule stabilizer, is a common chemotherapeutic agent used to treat various metastatic cancers. However, prolonged use results in various side effects and drug resistance. Flavonoids, such as baicalein, are accepted chemotherapeutic and dietary chemopreventive agents with many advantages, such as greater accessibility, affordability, and lower toxicity, compared with traditional chemotherapy agents. In this study, we evaluated whether baicalein enhances the effects of docetaxel on apoptosis and metastasis in 8505c ATC cells.

Methods

The 8505c cells were treated with baicalein or docetaxel individually and in combination. Cell viability was measured by MTT (thiazolyl blue tetrazolium bromide) assay, and apoptosis was detected by fluorescence microscopy of Hoechst-stained cells. The expression of apoptotic (Bax and caspase-3), anti-apoptotic (Bcl-2), angiogenic (vascular endothelial growth factor [VEGF], transforming growth factor β [TGF-β], E-cadherin, and N-cadherin), and signaling (extracellular signal-regulated kinase [ERK] mitogen activated protein kinase [MAPK], Akt, and mammalian target of rapamycin [mTOR]) proteins was determined by Western blot analysis.

Results

The combination of baicalein (50 or 100 µM) and docetaxel (10 nM) significantly inhibited proliferation and induced apoptosis compared with monotherapies. The combination treatment significantly inhibited the expression of Bax, caspase-3, VEGF, TGF-β1, E-cadherin, N-cadherin, and mTOR, but decreased the expression of Bcl-2 and significantly decreased the phosphorylation of ERK and Akt.

Conclusion

The combination of baicalein and docetaxel effectively induced apoptosis and inhibited metastasis in 8505c cells through downregulation of apoptotic and angiogenic protein expression and blocking of the ERK and Akt/mTOR pathways in 8505c cells. These results suggest that baicalein enhances the anticancer effects of docetaxel in ATC.

Citations

Citations to this article as recorded by  
  • Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review
    Sajad Fakhri, Seyed Zachariah Moradi, Farahnaz Faraji, Leila Kooshki, Kassidy Webber, Anupam Bishayee
    Cancer and Metastasis Reviews.2024; 43(1): 501.     CrossRef
  • Baicalein Alleviates Arsenic-induced Oxidative Stress through Activation of the Keap1/Nrf2 Signalling Pathway in Normal Human Liver Cells
    Qi Wang, Aihua Zhang
    Current Molecular Medicine.2024; 24(3): 355.     CrossRef
  • Natural products reverse cancer multidrug resistance
    Jia-Yu Zou, Qi-Lei Chen, Xiao-Ci Luo, Davaadagva Damdinjav, Usama Ramadan Abdelmohsen, Hong-Yan Li, Tungalag Battulga, Hu-Biao Chen, Yu-Qing Wang, Jian-Ye Zhang
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Identification of novel characteristic biomarkers and immune infiltration profile for the anaplastic thyroid cancer via machine learning algorithms
    C. Li, X. Dong, Q. Yuan, G. Xu, Z. Di, Y. Yang, J. Hou, L. Zheng, W. Chen, G. Wu
    Journal of Endocrinological Investigation.2023; 46(8): 1633.     CrossRef
  • Promising Role of the Scutellaria baicalensis Root Hydroxyflavone–Baicalein in the Prevention and Treatment of Human Diseases
    Marcelina Chmiel, Monika Stompor-Gorący
    International Journal of Molecular Sciences.2023; 24(5): 4732.     CrossRef
  • STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel
    Sandra M. Rocha, Daniel Nascimento, Rafaella S. Coelho, Ana Margarida Cardoso, Luís A. Passarinha, Sílvia Socorro, Cláudio J. Maia
    International Journal of Molecular Sciences.2023; 24(7): 6643.     CrossRef
  • Baicalein as Promising Anticancer Agent: A Comprehensive Analysis on Molecular Mechanisms and Therapeutic Perspectives
    A K M Helal Morshed, Supti Paul, Arafat Hossain, Tuli Basak, Md. Sanower Hossain, Md. Mehedi Hasan, Md. Al Hasibuzzaman, Tanjim Ishraq Rahaman, Md. Abdur Rashid Mia, Pollob Shing, Md Sohel, Shabana Bibi, Dipta Dey, Partha Biswas, Md. Nazmul Hasan, Long Ch
    Cancers.2023; 15(7): 2128.     CrossRef
  • The role of flavonoids in the regulation of epithelial‐mesenchymal transition in cancer: A review on targeting signaling pathways and metastasis
    Carina Proença, Marisa Freitas, Daniela Ribeiro, Ana T. Rufino, Eduarda Fernandes, José Miguel P. Ferreira de Oliveira
    Medicinal Research Reviews.2023; 43(6): 1878.     CrossRef
  • Developing a ternary conductive hydrogel of polyacrylamide, polyaniline, and carbon nanotube: A potential chemiresistive gas sensor
    Mohsen Peykari, Saeed Pourmahdian
    Journal of Composite Materials.2023; 57(27): 4291.     CrossRef
  • Inhibiting MEK1 R189 citrullination enhances the chemosensitivity of docetaxel to multiple tumour cells
    Teng Xue, Shujia Fei, Jian Gu, Nan Li, Pengxue Zhang, Xiaoqiu Liu, Paul R Thompson, Xuesen Zhang
    Philosophical Transactions of the Royal Society B: Biological Sciences.2023;[Epub]     CrossRef
  • Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6
    Shuqing Li, Zhihui Yi, Mingqing Li, Zhiling Zhu
    Journal of Ovarian Research.2023;[Epub]     CrossRef
  • Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin
    Poupak Fallahi, Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, Armando Patrizio, Sabrina Rosaria Paparo, Gianni Marone, Maria Rosaria Galdiero, Giovanni Guglielmi, Rudy Foddis, Alfonso Cristaudo, Alessandro Antonelli
    Seminars in Cancer Biology.2022; 79: 203.     CrossRef
  • Synergistic effects of BAY606583 on docetaxel in esophageal cancer through modulation of ERK1/2
    Zinab Mohammadi, Jahanbakhsh Asadi, Seyyed Mehdi Jafari
    Cell Biochemistry and Function.2022; 40(6): 569.     CrossRef
  • Regulation of Cell Signaling Pathways and Non-Coding RNAs by Baicalein in Different Cancers
    Ammad Ahmad Farooqi, Gulnara Kapanova, Sundetgali Kalmakhanov, Gulnur Tanbayeva, Kairat S. Zhakipbekov, Venera S. Rakhmetova, Marat K. Syzdykbayev
    International Journal of Molecular Sciences.2022; 23(15): 8377.     CrossRef
  • Crosstalk between xanthine oxidase (XO) inhibiting and cancer chemotherapeutic properties of comestible flavonoids- a comprehensive update
    Md Sohanur Rahaman, Md Afjalus Siraj, Md Arman Islam, Prayas Chakma Shanto, Ordha Islam, Md Amirul Islam, Jesus Simal-Gandara
    The Journal of Nutritional Biochemistry.2022; 110: 109147.     CrossRef
  • Anticancer effects of natural phytochemicals in anaplastic thyroid cancer (Review)
    Yitian Li, Jing Zhang, Huihui Zhou, Zhen Du
    Oncology Reports.2022;[Epub]     CrossRef
  • The Multifaceted Role of Baicalein in Cancer Management through Modulation of Cell Signalling Pathways
    Arshad Husain Rahmani, Ahmad Almatroudi, Amjad Ali Khan, Ali Yousif Babiker, Malak Alanezi, Khaled S. Allemailem
    Molecules.2022; 27(22): 8023.     CrossRef
  • Ouabain Effects on Human Anaplastic Thyroid Carcinoma 8505C Cells
    Mariana Pires Teixeira, Natalia Ferreira Haddad, Eliza Freitas Passos, Marcelle Novaes Andrade, Maria Luisa Arantes Campos, Joyle Moreira Carvalho da Silva, Camila Saggioro de Figueiredo, Elizabeth Giestal-de-Araujo, Denise Pires de Carvalho, Leandro Mira
    Cancers.2022; 14(24): 6168.     CrossRef
  • Baicalein Represses Cervical Cancer Cell Growth, Cell Cycle Progression and Promotes Apoptosis via Blocking AKT/mTOR Pathway by the Regulation of circHIAT1/miR-19a-3p Axis
    Jiaojiao Hu, Runkun Wang, Yi Liu, Jianbo Zhou, Ka Shen, Yun Dai
    OncoTargets and Therapy.2021; Volume 14: 905.     CrossRef
  • Phytochemicals in thyroid cancer: analysis of the preclinical studies
    Stefania Bulotta, Francesca Capriglione, Marilena Celano, Valeria Pecce, Diego Russo, Valentina Maggisano
    Endocrine.2021; 73(1): 8.     CrossRef
  • Cancer-associated fibroblasts (CAFs) in thyroid papillary carcinoma: molecular networks and interactions
    Jeehoon Ham, Bin Wang, Joseph William Po, Amandeep Singh, Navin Niles, Cheok Soon Lee
    Journal of Clinical Pathology.2021; 74(12): 759.     CrossRef
  • Clinical Study of Virtual Reality Augmented Technology Combined with Contrast-Enhanced Ultrasound in the Assessment of Thyroid Cancer
    Qinghua Liu, Jian Cheng, Jingjing Li, Lei Liu, Hongbo Li, Zhihan Lv
    Journal of Healthcare Engineering.2021; 2021: 1.     CrossRef
  • Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review
    Elika Verma, Aviral Kumar, Uzini Devi Daimary, Dey Parama, Sosmitha Girisa, Gautam Sethi, Ajaikumar B. Kunnumakkara
    Journal of Functional Foods.2021; 86: 104660.     CrossRef
  • E-cadherin on epithelial–mesenchymal transition in thyroid cancer
    Xiaoyu Zhu, Xiaoping Wang, Yifei Gong, Junlin Deng
    Cancer Cell International.2021;[Epub]     CrossRef
  • Combinatorial Therapies in Thyroid Cancer: An Overview of Preclinical and Clinical Progresses
    Gheysen Laetitia, Saussez Sven, Journe Fabrice
    Cells.2020; 9(4): 830.     CrossRef
  • Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer
    Daniela Gentile, Paola Orlandi, Marta Banchi, Guido Bocci
    Medical Oncology.2020;[Epub]     CrossRef
  • Interleukin-22 enhances chemoresistance of lung adenocarcinoma cells to paclitaxel
    Zhiliang Huang, Yu Gao, Dianchen Hou
    Human Cell.2020; 33(3): 850.     CrossRef
  • Plant natural products with anti-thyroid cancer activity
    Javad Sharifi-Rad, Sadegh Rajabi, Miquel Martorell, Maria Dolores López, María Trinidad Toro, Susi Barollo, Decio Armanini, Patrick Valere Tsouh Fokou, Giuseppe Zagotto, Giovanni Ribaudo, Raffaele Pezzani
    Fitoterapia.2020; 146: 104640.     CrossRef
  • Baicalein: A metabolite with promising antineoplastic activity
    Hardeep Singh Tuli, Vaishali Aggarwal, Jagjit Kaur, Diwakar Aggarwal, Gaurav Parashar, Nidarshana Chaturvedi Parashar, Muobarak Tuorkey, Ginpreet Kaur, Raj Savla, Katrin Sak, Manoj Kumar
    Life Sciences.2020; 259: 118183.     CrossRef
  • Impact of Antioxidant Natural Compounds on the Thyroid Gland and Implication of the Keap1/Nrf2 Signaling Pathway
    Ana Paunkov, Dionysios V. Chartoumpekis, Panos G. Ziros, Niki Chondrogianni, Thomas W. Kensler, Gerasimos P. Sykiotis
    Current Pharmaceutical Design.2019; 25(16): 1828.     CrossRef
  • Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
    Qingmei Ye, Kai Liu, Qun Shen, Qingyue Li, Jinghui Hao, Fangxuan Han, Ren-Wang Jiang
    Frontiers in Oncology.2019;[Epub]     CrossRef
  • Inhibition of Cancer Stem-Like Phenotype by Curcumin and Deguelin in CAL-62 Anaplastic Thyroid Cancer Cells
    Mehmet A. Kocdor, Hakan Cengiz, Halil Ates, Hilal Kocdor
    Anti-Cancer Agents in Medicinal Chemistry.2019; 19(15): 1887.     CrossRef
  • Induction of apoptotic but not autophagic cell death by Cinnamomum cassia extracts on human oral cancer cells
    Ching‐Han Yu, Shu‐Chen Chu, Shun‐Fa Yang, Yih‐Shou Hsieh, Chih‐Yi Lee, Pei‐Ni Chen
    Journal of Cellular Physiology.2019; 234(4): 5289.     CrossRef
  • Licochalcone A induces apoptotic cell death via JNK/p38 activation in human nasopharyngeal carcinoma cells
    Chun‐Yi Chuang, Cheng‐Ming Tang, Hsin‐Yu Ho, Chung‐Han Hsin, Chia‐Jui Weng, Shun‐Fa Yang, Pei‐Ni Chen, Chiao‐Wen Lin
    Environmental Toxicology.2019; 34(7): 853.     CrossRef
  • Rab23 contributes to the progression of colorectal cancer via protein kinase B and extracellular signal‑regulated kinase signaling pathways
    Tongbi Zhao, Dong Han, Huan Meng
    Oncology Letters.2019;[Epub]     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism